<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31945419</article-id>
<article-id pub-id-type="pmc">7204410</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2020.104746</article-id>
<article-id pub-id-type="manuscript">NIHMS1551653</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Striatal glutamate delta-1 receptor regulates behavioral flexibility
and thalamostriatal connectivity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jinxu</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shelkar</surname>
<given-names>Gajanan P.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gandhi</surname>
<given-names>Pauravi J.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gawande</surname>
<given-names>Dinesh Y.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoover</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Villalba</surname>
<given-names>Rosa M.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pavuluri</surname>
<given-names>Ratnamala</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Yoland</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dravid</surname>
<given-names>Shashank M.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Pharmacology and Neuroscience, Creighton
University School of Medicine, Omaha, NE 68178, USA</aff>
<aff id="A2"><label>b</label>Yerkes National Primate Research Center, Atlanta, GA 30329,
USA</aff>
<aff id="A3"><label>c</label>UDALL Center of Excellence for Parkinson’s Disease,
Atlanta, GA 30329, USA</aff>
<aff id="A4"><label>d</label>Dept. Neurology, Emory University, Atlanta, GA 30329,
USA</aff>
<author-notes>
<fn id="FN1">
<label>1</label>
<p id="P1">Equal contribution.</p>
</fn>
<fn fn-type="con" id="FN2">
<p id="P2">Author contributions</p>
<p id="P3"><italic>Participated in research design</italic>: Liu, Shelkar,
Gandhi, Gawande, Hoover, Villalba, Pavuluri, Smith and Dravid</p>
<p id="P4"><italic>Conducted experiments</italic>: Liu, Shelkar, Gandhi,
Gawande, Hoover, Villalba, Pavuluri</p>
<p id="P5"><italic>Performed data analysis</italic>: Liu, Shelkar, Gandhi,
Gawande, Hoover, Villalba, Pavuluri, Smith and Dravid</p>
<p id="P6"><italic>Wrote or contributed to writing of the manuscript</italic>:
Liu, Shelkar, Gandhi, Gawande, Villalba, Pavuluri, Smith and Dravid</p>
<p id="P7"><italic>Funding acquisition</italic>: Dravid, Smith</p>
</fn>
<corresp id="CR1"><label>*</label>Corresponding author at: Department of
Pharmacology, Creighton University, School of Medicine, 2500 California Plaza,
Omaha, NE 68178, USA. <email>ShashankDravid@creighton.edu</email> (S.M.
Dravid).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>5</month>
<year>2020</year>
</pub-date>
<volume>137</volume>
<fpage>104746</fpage>
<lpage>104746</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2020.104746-->
<permissions>
<license>
<license-p>This is an open access article under the CC BY-NC-ND license
(<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/BY-NC-ND/4.0/">http://creativecommons.org/licenses/BY-NC-ND/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract id="ABS1">
<p id="P8">Impaired behavioral flexibility and repetitive behavior is a common
phenotype in autism and other neuropsychiatric disorders, but the underlying
synaptic mechanisms are poorly understood. The trans-synaptic glutamate delta
(GluD)-Cerebellin 1-Neurexin complex, critical for synapse
formation/maintenance, represents a vulnerable axis for neuropsychiatric
diseases. We have previously found that GluD1 deletion results in reversal
learning deficit and repetitive behavior. In this study, we show that selective
ablation of GluD1 from the dorsal striatum impairs behavioral flexibility in a
water T-maze task. We further found that striatal GluD1 is preferentially found
in dendritic shafts, and more frequently associated with thalamic than cortical
glutamatergic terminals suggesting localization to projections from the thalamic
parafascicular nucleus (Pf). Conditional deletion of GluD1 from the striatum led
to a selective loss of thalamic, but not cortical, terminals, and reduced
glutamatergic neurotransmission. Optogenetic studies demonstrated functional
changes at thalamostriatal synapses from the Pf, but no effect on the
corticostriatal system, upon ablation of GluD1 in the dorsal striatum. These
studies suggest a novel molecular mechanism by which genetic variations
associated with neuropsychiatric disorders may impair behavioral flexibility,
and reveal a unique principle by which GluD1 subunit regulates forebrain
circuits.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS2">
<title>Graphical Abstract</title>
<p id="P9">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-1551653-f0007.jpg"></graphic>
</p>
</abstract>
<kwd-group>
<kwd>Cbln1</kwd>
<kwd>GluD1</kwd>
<kwd>glutamate</kwd>
<kwd>striatum</kwd>
<kwd>Parafascicular thalamus</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1">
<label>1.</label>
<title>Introduction</title>
<p id="P10">Impaired behavioral flexibility is a phenotype observed in several
neuropsychiatric disorders and most commonly in autism, Tourette syndrome and ADHD.
Although previous studies have found that cortical and striatal circuits support
cognitive flexibility, the knowledge of synaptic changes that underlie deficits in
this behavior, and its relationship to neuropsychiatric disorders remains
incomplete. Neurexins are strongly associated with neuropsychiatric disorders and
interact with a repertoire of post-synaptic proteins of which neuroligins are most
studied (reviewed (<xref ref-type="bibr" rid="R49">Sudhof, 2017</xref>, <xref ref-type="bibr" rid="R60">Yuzaki, 2018</xref>)). Recent studies have
demonstrated that GluDs interact with presynaptic Neurexin via the complement
pathway family protein cerebellin 1 (Cbln1) released from presynaptic terminals.
Together, the GluD-Cbln1-Neurexin forms a trans-synaptic complex that mediates the
development and maintenance of specific synapses in young and adult mice (<xref ref-type="bibr" rid="R54">Uemura et al., 2010</xref>; <xref ref-type="bibr" rid="R34">Matsuda et al., 2010</xref>). This function has been well
established at parallel fiber-Purkinje cell (PF-PC) glutamatergic synapses, where
loss of GluD2 or Cbln1 reduces number of PF-PC synapses and impairs normal LTD and
motor learning (<xref ref-type="bibr" rid="R61">Yuzaki and Aricescu,
2017</xref>).</p>
<p id="P11">In contrast to GluD2, the function of GluD1, which is enriched in
corticolimbic regions and striatum (<xref ref-type="bibr" rid="R28">Konno et al.,
2014</xref>; <xref ref-type="bibr" rid="R21">Hepp et al., 2015</xref>), is less
understood. Nonetheless, copy number variations (CNVs) and single nucleotide
polymorphism studies show a strong association of <italic>GRID1</italic> gene, that
codes for GluD1, with autism (<xref ref-type="bibr" rid="R15">Griswold et al.,
2012</xref>; <xref ref-type="bibr" rid="R37">Nord et al., 2011</xref>; <xref ref-type="bibr" rid="R47">Smith et al., 2009</xref>; <xref ref-type="bibr" rid="R13">Glessner et al., 2009</xref>) and schizoaffective disorders
(<xref ref-type="bibr" rid="R8">Edwards et al., 2012</xref>; <xref ref-type="bibr" rid="R10">Fallin et al., 2005</xref>; <xref ref-type="bibr" rid="R16">Guo
et al., 2007</xref>; <xref ref-type="bibr" rid="R14">Greenwood et al.,
2011</xref>; <xref ref-type="bibr" rid="R51">Treutlein et al., 2009</xref>). In
addition, missense mutations in <italic>GRID1</italic> underlie developmental delay
and intellectual disability ((<xref ref-type="bibr" rid="R52">Turner et al.,
2017</xref>); FENS Neuroscience 2016, C.16.B, Laumonnier and Toutain). Altered
GluD1 expression is found in Rett syndrome-patient derived neurons and in a mouse
model of Rett syndrome (<xref ref-type="bibr" rid="R33">Livide et al., 2015</xref>;
<xref ref-type="bibr" rid="R41">Patriarchi et al., 2016</xref>). These findings,
together with the strong association of neurexin with Tourette syndrome, autism and
schizoaffective disorders (<xref ref-type="bibr" rid="R49">Sudhof, 2017</xref>),
suggest that GluD1-Cbln1-Neurexin is a highly vulnerable node for neuropsychiatric
disorders. Thus, a better understanding of the organizing principle of GluD1 in the
forebrain may provide mechanisms underlying behavioral phenotypes in
neuropsychiatric disorders.</p>
<p id="P12">We have previously shown that GluD1 knockout mice exhibit impaired reversal
learning and repetitive behaviors (<xref ref-type="bibr" rid="R59">Yadav et al.,
2013</xref>). In the present study, we probed the potential mechanism of
impaired behavioral flexibility due to GluD1 deletion using a conditional knockout
strategy. Our findings demonstrate that GluD1 in the dorsal striatum regulates
behavioral flexibility in water T-maze test, and contributes to the anatomical and
functional integrity of the thalamostriatal over the corticostriatal system,
providing a mechanism by which genetic variations associated with neuropsychiatric
disorders may result in impaired behavioral flexibility.</p>
</sec>
<sec id="S2">
<label>2.</label>
<title>Materials and methods</title>
<p id="P13">Detailed materials and methods are provided as <xref ref-type="supplementary-material" rid="SD1">Supplementary Information</xref>.</p>
<sec id="S3">
<label>2.1.</label>
<title>Animals</title>
<p id="P14">Male and female mice were used in this study. GluD1 KO mice (<xref ref-type="bibr" rid="R12">Gao et al., 2007</xref>) were on 95% C57BL/6 and
remaining 129SvEv background. GluD1<sup>flox/flox</sup> mice (generous gift from
Dr. Pei Lung-Chen, on congenic C75BL/6 background) were crossed with Emx1-Cre
(congenic C57BL/6, 005628 Jackson Labs) or Rgs9-cre (mixed C57BL/6 and 129SvEv
background (<xref ref-type="bibr" rid="R5">Dang et al., 2006</xref>)) driver
mice to selectively ablate GluD1 from the corticolimbic region or striatum, as
previously described (<xref ref-type="bibr" rid="R32">Liu et al., 2018</xref>).
In animals without any surgical manipulation, electrophysiology and
immunohistochemical studies were carried out at 4–6 weeks of age and
3–4 months of age for behavioral studies. For mice with surgical
manipulation all studies were carried out at 3–4 months of age. All
experimental protocols were approved by the Creighton University Institutional
Animal Care and Use Committee Policies and Procedures.</p>
</sec>
<sec id="S4">
<label>2.2.</label>
<title>Stereotaxic surgery and viral delivery</title>
<p id="P15">Mice were anesthetized with isoflurane and placed in a stereotaxic
frame. Skull was exposed, and a small hole was drilled through the skull at the
coordinates for the dorsal striatum, ventral striatum or parafascicular nucleus
(Pf). The injection needle was lowered, and virus particles were delivered at a
rate of 1 nl/s (total volume 150 nl) using a UMP3 micro-syringe pump (World
Precision Instruments).</p>
</sec>
</sec>
<sec id="S5">
<label>3.</label>
<title>Behavior</title>
<sec id="S6">
<label>3.1.</label>
<title>Water T-maze</title>
<p id="P16">On day 1, the acquisition training was started and for every animal the
platform was kept on opposite side to the preferred side assessed during
habituation on day 0. Ten trials were carried out per day with an inter-trial
interval of ~10 min. Following scores were given; 0 for correct choice, 1 for
non-platform arm entry (incorrect choice), and 2 if after successfully finding
the platform mouse left the platform arm. Once the daily criterion of 80%
correct choices for four consecutive days was reached, reversal learning was
started in which platform location was switched to the opposite side arm. Total
errors (consistent entries between the incorrect arm and start arm),
preservative errors (incorrect arm entry) and regressive errors (any entry made
after successfully finding the platform) were analyzed.</p>
</sec>
</sec>
<sec id="S7">
<label>4.</label>
<title>Electrophysiology</title>
<p id="P17">Whole-cell electrophysiology voltage-clamp and current-clamp recordings were
performed as previously described (<xref ref-type="bibr" rid="R17">Gupta et al.,
2015</xref>; <xref ref-type="bibr" rid="R18">Gupta et al., 2016</xref>; <xref ref-type="bibr" rid="R32">Liu et al., 2018</xref>). 300-μm thick
parasagittal or approximately 30° oblique horizontal sections were prepared
using vibrating microtome. Electrical-evoked corticostriatal EPSCs were induced by a
bipolar tungsten electrode placed in the layer 6 of the cortex. Thalamostriatal
EPSCs were evoked by 5 ms 470 nM LED light delivered by a fiber optic cannula.</p>
</sec>
<sec id="S8">
<label>5.</label>
<title>Immunohistochemistry</title>
<sec id="S9">
<label>5.1.</label>
<title>Confocal microscopy</title>
<p id="P18">Immunohistochemistry and confocal imaging was conducted, as previously
described (<xref ref-type="bibr" rid="R17">Gupta et al., 2015</xref>; <xref ref-type="bibr" rid="R18">Gupta et al., 2016</xref>). For vGluT1 and vGluT2
puncta analysis, the central dorsal striatum region was analyzed.
Co-localization and puncta number were analyzed using Volocity software
(PerkinElmer Inc. Coventry, United Kingdom). The number of puncta per image was
filtered based on intensity and size range (≥
0.1–0.3μm<sup>3</sup>) and 3–8 images were analyzed per
animal.</p>
</sec>
<sec id="S10">
<label>5.2.</label>
<title>Immuno-electron microscopy</title>
<p id="P19">Brains were EM immunostained with a highly specific GluD1 antibody
(<xref ref-type="bibr" rid="R28">Konno et al., 2014</xref>) using the
immunoperoxidase method, as described in our previous studies (<xref ref-type="bibr" rid="R42">Raju et al., 2006</xref>). Random series of 50–55
micrographs of striatal tissue from the surface of the blocks that contained
immunoreactive profiles were taken at 25000×. GluD1-immunoreactive
elements that could be categorized as neuronal or glial profiles were counted
and expressed as relative percentage of total labeled elements.</p>
</sec>
</sec>
<sec id="S11">
<label>6.</label>
<title>Results</title>
<sec id="S12">
<label>6.1.</label>
<title>Striatal, but not corticolimbic, GluD1 regulates behavioral
flexibility</title>
<p id="P20">We first evaluated the effect of ablation of GluD1 from the
corticolimbic region and striatum, which are the two most enriched regions of
GluD1 expression (<xref ref-type="bibr" rid="R28">Konno et al., 2014</xref>;
<xref ref-type="bibr" rid="R21">Hepp et al., 2015</xref>), on behavioral
flexibility in a water T-maze task. Selective deletion of GluD1 from
corticolimbic region and striatum was achieved by crossing
GluD1<sup>flox/flox</sup> with Emx-1-Cre as previously described (<xref ref-type="bibr" rid="R32">Liu et al., 2018</xref>). In water T-maze task, no
significant difference was observed in mice with corticolimbic deletion of GluD1
(corticolimbic-GluD1 KO) in habit acquisition learning or in the reversal
learning (<xref ref-type="fig" rid="F1">Fig. 1B</xref>–<xref ref-type="fig" rid="F1">B</xref>”‘; <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1A</xref>).
Corticolimbic-GluD1 KO were also similar to wildtype in rotarod test and open
field test in total distance traveled (<xref ref-type="fig" rid="F1">Fig.
1C</xref>, <xref ref-type="fig" rid="F1">D</xref>). We then conducted water
T-maze test in mice with striatal ablation of GluD1 (St-GluD1 KO), in which most
GluD1 protein was abolished from the dorsal striatum (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1D</xref>, <xref ref-type="supplementary-material" rid="SD1">E</xref>). In St-GluD1 KO mice,
no significant difference was observed in percent errorless trials across days
(<xref ref-type="fig" rid="F1">Fig. 1F</xref>), but they took a
significantly shorter time to find the platform (<xref ref-type="fig" rid="F1">Fig. 1F</xref>’). In addition, significantly fewer days were taken
to reach the criteria for habit acquisition learning (WT 4.250 ± 0.6756
vs. St-GluD1 KO 1.714 ± 0.4118, <italic>p</italic> = .0030, unpaired
t-test). In reversal learning, St-GluD1 KO mice committed significantly more
total errors than WT in the first trial (WT 2.167 ± 0.5198 vs. St-GluD1
KO 4.500 ± 0.9002, <italic>p</italic> = .0421, unpaired t-test). The
number of total errors on day 1 (including trial 1 to trial 10) was
significantly higher in St-GluD1 KO mice than WT animals (<xref ref-type="fig" rid="F1">Fig. 1F</xref>”). When the total errors on Day 1 were
divided into perseverative or regressive errors, St-GluD1 KO mice made
significantly more preservative errors in trial 1 on day 1 (WT 1.583 ±
0.2289 vs. St-GluD1 KO 2.929 ± 0.4625, p = .0174, unpaired t-test) and in
total preservative errors on day 1 and day 2 than wildtype mice (<xref ref-type="fig" rid="F1">Fig. 1F</xref>”‘). No difference was observed
in the percent trials completed without error during reversal training (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1E</xref>).
Overall, these results suggest that striatal GluD1, but not corticolimbic GluD1,
regulates behavioral flexibility during the water T-maze task. In rotarod test,
which is used to assess motor coordination and repetitive behaviors (<xref ref-type="bibr" rid="R43">Rothwell et al., 2014</xref>), St-GluD1 KO mice
showed greater latency to fall compared to wildtype, with no change in open
field test (<xref ref-type="fig" rid="F1">Fig. 1G</xref>, <xref ref-type="fig" rid="F1">H</xref>). We also tested corticlimbic-GluD1 KO and St-GluD1
KO in other behavioral and cognitive tasks. No differences were observed in
other motor, sensorimotor and cognitive tests in either genotype (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1B–I</xref>).
These results suggest that deletion of striatal GluD1 selectively impairs
behavioral flexibility, but improves habit learning behaviors.</p>
</sec>
<sec id="S13">
<label>6.2.</label>
<title>Reduced behavioral flexibility maps to GluD1 in the dorsal striatum</title>
<p id="P21">In order to better understand the origin of impaired behavioral
flexibility upon GluD1 ablation from the striatum, we tested the effect of local
ablation of GluD1 by cre recombinase expression using viral vectors in
GluD1<sup>flox/flox</sup> mice. AAV-eGFP or AAV-eGFP-Cre were injected into
the dorsal striatum (centromedial region) of GluD1<sup>flox/flox</sup> mice
(<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.
2A</xref>–<xref ref-type="supplementary-material" rid="SD1">B</xref>), and after sufficient survival time for optimal expression water
T-maze test was conducted. Similar to St-GluD1 KO in the water T-maze task, the
AAV-eGFP-Cre mice took a significantly shorter time to find the platform than
AAV-eGFP animals on testing days 2, 5 and 6 (<xref ref-type="fig" rid="F2">Fig.
2B</xref>’). However, the percentage of trials without errors was not
significantly different (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). In the
reversal learning task, the deficits in the AAV-eGFP-Cre mice were consistent
with those described in St-GluD1 KO mice with more total perseverative errors on
day 1 and day 2 than in control animals (<xref ref-type="fig" rid="F2">Fig.
2B</xref>”, <xref ref-type="fig" rid="F2">B</xref>″’).
In contrast, mice with ventral striatum GluD1 deletion did not exhibit
differences in the number of total or preservative errors in the water T-maze
test (<xref ref-type="fig" rid="F2">Fig. 2F</xref>”), indicating that
GluD1 function in the dorsal striatum is critical for the regulation of
behavioral flexibility. Deletion of GluD1 from the dorsal striatum, but not the
ventral striatum, also led to an increase in latency to fall in rotarod test
with no change in the total distance traveled in the open field test (<xref ref-type="fig" rid="F2">Fig. 2C</xref>, <xref ref-type="fig" rid="F2">D</xref>, <xref ref-type="fig" rid="F2">G</xref>, <xref ref-type="fig" rid="F2">H</xref>).</p>
</sec>
<sec id="S14">
<label>6.3.</label>
<title>Cellular and subcellular localization of GluD1 immunoreactivity in the
striatum</title>
<p id="P22">To determine the potential sites where GluD1 may mediate its functional
effects in the striatum, we assessed the localization of GluD1 using light,
electron and confocal microscopy. At the light microscopic level, GluD1
immunoreactivity is heavily expressed in the striatum of WT mice, but the
staining is completely abolished in GluD1-KO mice, demonstrating the specificity
of the GluD1 antibody used in this study (<xref ref-type="fig" rid="F3">Fig.
3A</xref>–<xref ref-type="fig" rid="F3">B</xref>). Although intense
across the whole striatum, patches of striatal neuropil display a lower
intensity of immunostaining than neighboring regions, a pattern reminiscent of
the patch/matrix striatal compartmentation (<xref ref-type="bibr" rid="R22">Herkenham and Pert, 1981</xref>). In the electron microscope, striatal
GluD1 immunoreactivity was predominantly found in dendritic shafts (47.9
± 1.2% of total GluD1-labeled elements) and glial processes (37.7
± 2.5%) over dendritic spines (14.3 ± 2.6%) (<xref ref-type="fig" rid="F3">Fig. 3B</xref>–<xref ref-type="fig" rid="F3">F</xref>). Relevant to these results, GluD1 mRNA has been reported in
oligodendrocyte precursor cells (OPCs) (<xref ref-type="bibr" rid="R31">Larson
et al., 2016</xref>; <xref ref-type="bibr" rid="R45">Saunders et al.,
2018</xref>), a cell-type known to interact with neurons via axo-glial
synapses (<xref ref-type="bibr" rid="R3">Bergles et al., 2000</xref>).</p>
<p id="P23">The striatum receives major excitatory inputs from the thalamus and
cortex that can be distinguished by vGluT2- and vGluT1-positive terminals,
respectively (<xref ref-type="bibr" rid="R11">Fremeau Jr et al., 2001</xref>).
In confocal microscopy, our findings indicate that GluD1-immunoreactive elements
were far more frequently co-localized with vGluT2 (thalamic)- than vGluT1
(cortical)-immunoreactive puncta (vGluT1 1.12 ± 1.02 vs. vGluT2 10.31
± 1.46 GluD1+ elements/2000 μm<sup>2</sup> of striatal tissue)
(<xref ref-type="fig" rid="F3">Fig. 3G</xref>), thereby suggesting a
preferential association of GluD1 with thalamostriatal over corticostriatal
terminals.</p>
</sec>
<sec id="S15">
<label>6.4.</label>
<title>Deletion of striatal GluD1 reduces excitatory neurotransmission in MSNs and
thalamostriatal vGluT2 expression</title>
<p id="P24">To understand the potential synaptic functions of striatal GluD1, we
first recorded mEPSC and mIPSC from MSNs in both the constitutive and St-GluD1
KO models. A significant reduction in the frequency, but not the amplitude, of
mEPSC was observed in MSNs of St-GluD1 mice (<xref ref-type="fig" rid="F4">Fig.
4A</xref>). No significant change in mIPSC frequency and amplitude was
observed (<xref ref-type="fig" rid="F4">Fig. 4B</xref>). In current-clamp
recordings, a significant reduction in spike frequency of MSNs at higher current
injections was observed in St-GluD1 KO further suggesting reduced excitability
of MSNs in these animals (<xref ref-type="fig" rid="F4">Fig. 4C</xref>). No
change in the resting membrane potential, input resistance or rheobase was
observed (<xref ref-type="fig" rid="F4">Fig. 4D</xref>). When other features of
excitability were analyzed a greater accommodation was seen in St-GluD1 KO mice
at 300 pA current injection but not 200 pA current injection (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 3A</xref>, <xref ref-type="supplementary-material" rid="SD1">B</xref>). No changes were
observed in the first spike latency or last inter-spike interval in St-GluD1 KO
(<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.
3C</xref>, <xref ref-type="supplementary-material" rid="SD1">D</xref>).
Reduction in mEPSC frequency, with no change in mIPSC properties, was also
observed in constitutive GluD1 KO (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 4A</xref>, <xref ref-type="supplementary-material" rid="SD1">B</xref>).</p>
<p id="P25">We next assessed the changes in number of vGluT1- and
vGluT2-immunoreactive puncta in the dorsal striatum of St-GluD1 KO mice to
determine whether the reduced mEPSC frequency seen in MSNs of these animals was
due to a specific reduction in the prevalence of cortical or thalamic terminals.
This analysis revealed a significant reduction in the prevalence of
vGluT2-positive puncta, with no change in vGluT1 puncta counts, in the dorsal
striatum of St-GluD1 KO mice (<xref ref-type="fig" rid="F4">Fig. 4E</xref>). A
specific reduction in vGluT2 puncta counts in the dorsal striatum was also
observed in constitutive GluD1 KO mice (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 5A</xref>). We also
assessed the changes in thalamic and cortical terminals in mice with selective
ablation of GluD1 in the dorsal striatum using AAVs. A significant reduction in
the number of striatal vGluT2, but not vGluT1, puncta was seen in the
GluD1-ablated striatal region (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 5B</xref>, <xref ref-type="supplementary-material" rid="SD1">C</xref>).</p>
</sec>
<sec id="S16">
<label>6.5.</label>
<title>Pf-MSN synapses show higher AMPA/NMDA ratio upon deletion of striatal
GluD1</title>
<p id="P26">The enrichment of GluD1 in dendritic shafts suggests that GluD1 may
localize preferentially to projections from parafascicular nuclei of the
thalamus (Pf) since it is the major source of asymmetric axo-dendritic synapses
in the striatum (<xref ref-type="bibr" rid="R7">Dube et al., 1988</xref>; <xref ref-type="bibr" rid="R44">Sadikot et al., 1992</xref>). Additionally, Pf
shows strong expression of Cbln1 (<xref ref-type="bibr" rid="R35">Miura et al.,
2006</xref>; <xref ref-type="bibr" rid="R38">Otsuka et al., 2016</xref>)
which the major synaptogenic partner of GluDs. This hypothesis is further
supported by immunohistochemical results demonstrating that GluD1 is
preferentially co-localized with thalamic terminals and that loss of GluD1
specifically reduces the number of thalamostriatal terminals. Thus, we
determined if St-GluD1 deletion affects glutamatergic transmission and other
neuroplastic properties of Pf-MSN synapses. To do so, we used optogenetics to
compare the effects of light activation of Pf-striatal axons on MSNs activity
between WT and St-GluD1-KO mice. AAV-ChR2 was injected into the Pf, and after
sufficient expression, ex vivo optogenetic experiments were conducted.</p>
<p id="P27">Mice in which the viral vector injection sites spread outside the
nuclear confines of Pf were not used. No change in paired-pulse ratio was
observed at Pf-MSN synapses in St-GluD1 KO mice (<xref ref-type="fig" rid="F5">Fig. 5C</xref>). As previously reported (<xref ref-type="bibr" rid="R9">Ellender et al., 2013</xref>), the ratio of AMPA/NMDA receptor currents at
Pf-MSN synapses was smaller than at corticostriatal synapses in WT mice.
However, a significant increase in the AMPA/NMDA receptor current ratio was
found in St-GluD1 KO mice (<xref ref-type="fig" rid="F5">Fig. 5D</xref>).
Deletion of striatal GluD1 did not significantly affect the rectification index
of AMPA currents suggesting potentially no change in composition (<xref ref-type="fig" rid="F5">Fig. 5E</xref>). We also conducted ex vivo optogenetic
experiments to determine input-output ratio at Pf-MSN in wildtype and St-GluD1
KO, however these were not informative due to the variability in infection
efficiency across animals. As an alternate strategy to evaluate whether the
shift in AMPA/NMDA ratio may be due to change in NMDA receptor currents, we
measured NMDA receptor sEPSCs. A significant reduction in the frequency of NMDA
receptor sEPSC, but no change in amplitude, was observed in GluD1 KO (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 6A</xref>),
suggesting minimal postsynaptic effect. It is also possible that sEPSC
recordings failed to detect specific changes of Pf-MSN synapses. We further
analyzed synaptoneurosomal preparations from the dorsal striatum of wildtype and
St-GluD1 KO mice to examine if there were any changes in the expression of AMPA
and NMDA receptor subunits. No change was observed in the expression of total
AMPA receptor subunits detected using pan-AMPA antibody in St-GluD1 KO. However,
a significant reduction in GluN1 subunit expression was observed in St-GluD1 KO
(<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.
6B</xref>). Thus, it is possible that reduced NMDA receptor content is
responsible for the increase in AMPA/NMDA ratio at Pf-MSN synapses.</p>
<p id="P28">Because plasticity mechanisms such as long-term depression may underlie
reversal learning, we further tested whether the loss of GluD1 affected LTD at
Pf-MSN synapses. LTD was induced by activation of mGluR1/5 receptors using DHPG.
DHPG produced a similar reduction in amplitude of light-evoked AMPA EPSCs at
Pf-MSN synapses in WT vs St-GluD1 KO mice (<xref ref-type="fig" rid="F5">Fig.
5F</xref>). Along the same line, the synaptic depression effects of D-serine
on the amplitude of AMPA-mediated EPSCs at Pf-MSN synapses were not
significantly different between WT and St-GluD1 KO mice (<xref ref-type="fig" rid="F5">Fig. 5G</xref>). These data suggest that GluD1 is not
necessary for these forms of striatal synaptic plasticity.</p>
</sec>
<sec id="S17">
<label>6.6.</label>
<title>No functional changes at corticostriatal synapses upon striatal deletion of
GluD1</title>
<p id="P29">We next examined whether GluD1 affected properties of corticostriatal
synapses in St-GluD1 KO animals. We found no change in paired-pulse
facilitation, AMPA/NMDA ratio and spike threshold at cortico-striatal synapses
in MSNs of these mice compared to WT (<xref ref-type="fig" rid="F6">Fig.
6A</xref>–<xref ref-type="fig" rid="F6">C</xref>). Cortico-striatal
synapses also appeared to be functionally intact in constitutive GluD1 KO with
no change in AMPA/NMDA ratio and paired-pulse ratio or DHPG-induced LTD (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7A</xref> to
<xref ref-type="supplementary-material" rid="SD1">C</xref>). Additionally,
D-serine did not affect DHPG-induced LTD in WT mice (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7D</xref>). No change
in DHPG-induced LTD was noticed when analyzing mEPSC in MSNs or CA1 neurons
which are also enriched in GluD1 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8A</xref>, <xref ref-type="supplementary-material" rid="SD1">B</xref>). Moreover, unlike
dorsal striatum MSNs, CA1 neuron mEPSC characteristics were unchanged in GluD1
KO (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig.
8C</xref>), suggesting region-specific effects of GluD1 on excitatory
neurotransmission.</p>
<p id="P30">Recent studies have suggested that activation of metabotropic glutamate
receptors 1/5 (mGluR1/5) may induce ion channel currents via the GluD receptors
(<xref ref-type="bibr" rid="R1">Ady et al., 2014</xref>; <xref ref-type="bibr" rid="R2">Benamer et al., 2018</xref>). We examined whether this
property may be altered in GluD1 KO which could affect behavior. Thus, we
evaluated whether DHPG induces GluD1-dependent ion channel currents in striatal
MSNs and CA1 pyramidal neurons. In MSNs, no significant change in baseline was
observed with DHPG in both WT and St-GluD1 KO mice (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 9A</xref>). Similarly,
although DHPG application led to a slow current in CA1 hippocampal neurons, its
amplitude was not significantly different between WT and GluD1 KO animals (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 9B</xref>).
Together, the behavioral changes induced by GluD1 depletion in the dorsal
striatum cannot be explained by dysregulation of mGluR1/5 function.</p>
</sec>
</sec>
<sec id="S18">
<label>7.</label>
<title>Discussion</title>
<sec id="S19">
<label>7.1.</label>
<title>GluD1 functions as a synaptic organizer in the striatum</title>
<p id="P31">In addition to the canonical neurexin-neuroligin adhesion molecules,
recent studies have identified several proteins that may serve as synaptic
organizers by inducing formation and/or maintenance of specific synapses. Among
these complement family proteins, C1ql1 and Cblns as well as glia-derived
molecules such as hevin, play a critical role in formation/maintenance of
cerebellar and cortical synapses (<xref ref-type="bibr" rid="R49">Sudhof,
2017</xref>; <xref ref-type="bibr" rid="R60">Yuzaki, 2018</xref>). The
GluDs, which bind to Cbln1 with their aminoterminal domain, have long been
considered orphan receptors due to lack of ligand-gated ion channel activity,
are now known as synaptic organizers in the cerebellar cortex. However, their
role outside the cerebellar cortex remains largely unknown. Our findings
identify a unique synaptic organizer property of GluD1 in the dorsal striatum
whereby it plays a role in the maintenance of thalamostriatal, but not
corticostriatal, glutamatergic synapses. We found that GluD1 was preferentially
localized to dendritic shafts, the main synaptic target of thalamic terminals
from the Pf (<xref ref-type="bibr" rid="R7">Dube et al., 1988</xref>; <xref ref-type="bibr" rid="R44">Sadikot et al., 1992</xref>; <xref ref-type="bibr" rid="R42">Raju et al., 2006</xref>), and that ablation of GluD1 led to
reduced excitatory neurotransmission in MSNs and decreased prevalence of vGuT2
(putatively thalamic) terminals in the dorsal striatum. Further evidence for
GluD1 association with Pf-striatal projections come from our light microscopic
data (<xref ref-type="fig" rid="F3">Fig. 3A</xref>) showing a lower level of
GluD1 expression in presumed striatal patches, a striatal compartment known to
be devoid of Pf inputs (<xref ref-type="bibr" rid="R22">Herkenham and Pert,
1981</xref>). Since no change in paired pulse ratio was observed, these
results suggest that reduced mEPSC was not due to a change in release
probability, but most likely a reduced number of functional glutamatergic
synapses. Because of the specific enrichment of Cbln1, the synaptogenic partner
of GluD1, in Pf, and the known role of Cbln/GluD complex in synapse
formation/maintenance in other brain regions, we suggest that the lower
excitatory neurotransmission recorded in striatal neurons may result from a
specific loss of Pf-MSN terminals. Since the optogenetic stimulation of Pf-MSN
synapses was still intact in St-GluD1 KO, it suggests that loss of GluD1 does
not completely eliminate Pf-MSN synapses. Instead, the remaining Pf-MSN synapses
exhibit a shift in AMPA/NMDA ratio, but no change in chemical LTD mechanisms.
Additional electrophysiology experiments are needed to determine whether
deletion of GluD1 affects other forms of plasticity at Pf-MSN synapses. We have
previously found a reduction in AMPA receptor subunit expression and an increase
in NMDA receptor subunit expression in prefrontal cortex and hippocampus of
GluD1 KO, and a contrasting increase in AMPA and kainate subunit expression in
the amygdala (<xref ref-type="bibr" rid="R58">Yadav et al., 2012</xref>; <xref ref-type="bibr" rid="R59">Yadav et al., 2013</xref>). Thus, the increase in
AMPA/NMDA ratio at Pf-MSN synapses in St-GluD1 KO is reminiscent of changes
observed upon GluD1 deletion in amygdala. In contrast to the thalamostriatal
system, the corticostriatal synapses were intact after GluD1 deletion.</p>
<p id="P32">The preferential role of GluD1 in the regulation of Pf-MSN synapses is
likely due to the strong and specific expression of Cbln1 in the Pf, known as
the main source of thalamostriatal projections in rodents (<xref ref-type="bibr" rid="R35">Miura et al., 2006</xref>; <xref ref-type="bibr" rid="R38">Otsuka et al., 2016</xref>). Although Cbln2 is also expressed in cortical
and Pf neurons, its affinity for GluD1 is significantly lower than that of Cbln1
(<xref ref-type="bibr" rid="R55">Wei et al., 2012</xref>). Thus, the
interactions between GluD1 and Cbln2 may play a relatively minor role in
regulating corticostriatal and thalamostriatal synapses, compared to the
regulatory functions of GluD1-Cbln1 interactions upon thalamostriatal synapses
from Pf. We have previously found that ablation of GluD1 does not affect the
excitatory neurotransmission in the prefrontal cortex, hippocampus or nucleus
accumbens suggesting that there may be other compensatory mechanisms that
normalize the excitatory neurotransmission in these regions ((<xref ref-type="bibr" rid="R17">Gupta et al., 2015</xref>, <xref ref-type="bibr" rid="R32">Liu et al., 2018</xref>), current study). However, in both complete and
St-GluD1 KO mice used in this study, we observed a reduction in the frequency of
mEPSC and vGluT2 puncta suggesting a specific reduction in thalamostriatal
glutamatergic innervation. Thus, our findings suggest that GluD1 is obligatory
for the maintenance of excitatory thalamostriatal synapses on MSNs.</p>
<p id="P33">In the cerebellar cortex, a role of GluD2 in mGluR1-induced LTD is well
established (<xref ref-type="bibr" rid="R26">Kashiwabuchi et al., 1995</xref>)
and GluDs are known to interact via other signaling mechanisms with mGluRs
(<xref ref-type="bibr" rid="R53">Uemura et al., 2004</xref>; <xref ref-type="bibr" rid="R27">Kato et al., 2012</xref>; <xref ref-type="bibr" rid="R50">Suryavanshi et al., 2016</xref>). Based on these observations and the
potential role of this form of plasticity in reversal learning, we evaluated the
role of GluD1 in corticostriatal and thalamostriatal synaptic plasticity.
Consistent with previous reports (<xref ref-type="bibr" rid="R56">Wu et al.,
2015</xref>), we found an initial greater depression of corticostriatal than
thalamostriatal synapses upon application of DHPG, but GluD1 loss did not affect
DHPG-induced LTD at either synapses. Although delta receptors do not function as
typical iGluRs, they have a ligandbinding domain similar to the GluN1 subunit
where D-serine, glycine and other smaller amino acids can bind (<xref ref-type="bibr" rid="R36">Naur et al., 2007</xref>; <xref ref-type="bibr" rid="R57">Yadav et al., 2011</xref>; <xref ref-type="bibr" rid="R30">Kristensen et
al., 2016</xref>). Importantly, this interaction has been found to induce
conformational changes in delta receptors and produce GluD2-dependent LTD at
immature PF-PC synapses (<xref ref-type="bibr" rid="R25">Kakegawa et al.,
2011</xref>). We found that D-serine application led to a reduction in the
amplitude of EPSCs at Pf-MSN synapses, but this was not significantly affected
by ablation of GluD1 subunit, suggesting that GluD1 is not necessary for this
form of plasticity. Because this neuroplastic effect was observed in the
presence of NMDAR blockers AP5 and MK-801, it suggests that either GluD2 or
GluN3-containing NMDA receptors or some unknown mechanisms may be responsible
for this form of plasticity. Future studies are needed to clarify this issue.
Although we did not test D-serine effect alone at corticostriatal synapses, we
did not find a significant effect of D-serine on DHPG-induced LTD, which may be
interpreted as saturation of LTD response or that D-serine does not induce LTD
at corticostriatal synapses. Thus, although GluD1 is obligatory for maintenance
of synapses and potentially synaptic composition, synaptic depression is not
affected by loss of GluD1. Thus, GluD1 and GluD2 are similar is some function,
but diverge in other. Difference in the C-terminal interaction of the two
receptors may be responsible for some of the divergences.</p>
</sec>
<sec id="S20">
<label>7.2.</label>
<title>Thalamostriatal synaptic dysfunction in neuropsychiatric and neurological
disorders</title>
<p id="P34">As discussed earlier, genetic studies demonstrate strong association of
GRID1 with autism and schizoaffective disorders. In addition, Neurexin mutations
are associated with Tourette syndrome, autism and szhizoaffective disorders
(<xref ref-type="bibr" rid="R49">Sudhof, 2017</xref>). Thus,
GluD1-Cbln1-Neurexin is a highly vulnerable node for neuropsychiatric disorders.
One of the core symptoms in autism, Tourette syndrome and ADHD is increase in
repetitive behaviors and impaired behavioral flexibility. Previous studies have
used a wide variety of manipulations, primarily lesion and deactivation of Pf,
to demonstrate a role of the Pf-striatal system in behavioral flexibility (<xref ref-type="bibr" rid="R4">Bradfield and Balleine, 2017</xref>). The
thalamostriatal pathway is relevant to Tourette syndrome, ADHD and OCD since DBS
of CM/Pf relieve symptoms in some patients (<xref ref-type="bibr" rid="R48">Smith et al., 2014</xref>). Despite this information, our knowledge of
synaptic mechanisms that underlie behavioral inflexiblity remains incomplete.
Using region-specific ablation of GluD1, we found a strong phenotype of impaired
behavioral flexibility in water T-maze test in mice with specific GluD1 ablation
in the dorsal striatum. Interestingly, these animals also demonstrated faster
habit acquisition and time to task completion. In addition, deletion of GluD1
from the dorsal striatum led to better performance in rotarod test with higher
latency to fall which is also relevant to higher repetitive behavior. These
behavioral findings are consistent with our previous observations that
constitutive GluD1 KO mice exhibit greater task completion and lower working
memory error in an 8-arm radial maze task, but display slower learning in a
water maze reversal task (<xref ref-type="bibr" rid="R59">Yadav et al.,
2013</xref>). In optogenetic studies, we identified a specific increase in
AMPA/NMDA ratio at Pf-MSN synapses upon GluD1 ablation. We hypothesize that this
change in synaptic function may enhance plasticity mechanisms which facilitate
learning during acquisition phase and impair behavioral flexibility during
reversal learning. Future studies using genetic manipulations to control Pf-MSN
synapses will be necessary to identify the precise molecular switch that
underlies impaired behavioral flexibility.</p>
<p id="P35">In addition to cognitive function in neuropsychiatric disorders, the
thalamostriatal system is also important in neurological disorders. Pf undergoes
severe neuronal loss in Parkinson’s and Huntington diseases (PD and HD)
(<xref ref-type="bibr" rid="R20">Henderson et al., 2000</xref>; <xref ref-type="bibr" rid="R19">Heinsen et al., 1996</xref>) and it has been
suggested that degeneration of the Pf-MSNs thalamostriatal system may contribute
to cognitive impairments associated with these disorders (<xref ref-type="bibr" rid="R48">Smith et al., 2014</xref>). The reports of reduced Pf
activity and Pf-MSN neurotransmission in PD models (<xref ref-type="bibr" rid="R39">Parker et al., 2016</xref>; <xref ref-type="bibr" rid="R40">Parr-Brownlie et al., 2009</xref>), and evidence that deep brain
stimulation (DBS) of CM/Pf provides relief of symptoms in PD patients (<xref ref-type="bibr" rid="R29">Krauss et al., 2002</xref>; <xref ref-type="bibr" rid="R6">DeLong and Wichmann, 2015</xref>; <xref ref-type="bibr" rid="R46">Sharma et al., 2017</xref>) further support the functional
importance of this system in PD. Our results of a critical role of GluD1 in
regulating thalamostriatal synapses together with the evidence that both Cbln1
and Neurexin S4+ variant, which interact with Cbln1-GluD1, are controlled in an
activity-dependent manner (<xref ref-type="bibr" rid="R23">Iijima et al.,
2009</xref>; <xref ref-type="bibr" rid="R24">Iijima et al., 2011</xref>)
suggest that changes in expression in response to pathological insults can
precipitate synaptic dysfunction in neurological disorders such as PD and
HD.</p>
</sec>
</sec>
<sec id="S21">
<label>8.</label>
<title>Conclusion</title>
<p id="P36">In conclusion, we have identified a unique role of GluD1 in the organization
of neural circuits in the dorsal striatum which provides a mechanism by which genes
associated with neuropsychiatric disorders may lead to precipitation of impaired
behavioral flexibility. Because both Cbln1 and splicing of neurexin are controlled
in an activity-dependent manner (<xref ref-type="bibr" rid="R23">Iijima et al.,
2009</xref>, <xref ref-type="bibr" rid="R24">Iijima et al., 2011</xref>), it is
an intriguing possibility that the GluD1-Cbln1-Neurexin complexes at thalamostriatal
synapses may serve as a physiological switch to govern behavioral flexibility both
in normal and disease states.</p>
</sec>
<sec id="SM1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>1</label>
<media id="d36e882" orientation="portrait" position="anchor" xlink:href="NIHMS1551653-supplement-1.docx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>2</label>
<media id="d36e886" orientation="portrait" position="anchor" xlink:href="NIHMS1551653-supplement-2.docx"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S22">
<title>Acknowledgements</title>
<p id="P37">The authors are thankful to Anna Ayala, Lorenzo Rivera, Susan Jenkins and
Jean-Francois Pare for excellent technical help.</p>
<p id="P38">Funding</p>
<p id="P39">This work was supported by grants from the National Science Foundation
#1456818 (SMD), National Institutes of Health NS104705 (SMD), National Institutes of
Health MH116003 (SMD) and Yerkes National Primate Center National Institutes of
Health/ORIP base grant P51OD11132 (YS). The authors note no conflict of
interest.</p>
</ack>
<fn-group>
<fn id="FN3">
<p id="P40">Appendix A. Supplementary data</p>
<p id="P41">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.nbd.2020.104746">https://doi.org/10.1016/j.nbd.2020.104746</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="R1">
<mixed-citation publication-type="journal"><name><surname>Ady</surname><given-names>V</given-names></name>, <name><surname>Perroy</surname><given-names>J</given-names></name>, <name><surname>Tricoire</surname><given-names>L</given-names></name>, <name><surname>Piochon</surname><given-names>C</given-names></name>, <name><surname>Dadak</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Dusart</surname><given-names>I</given-names></name>, <name><surname>Fagni</surname><given-names>L</given-names></name>, <name><surname>Lambolez</surname><given-names>B</given-names></name>, <name><surname>Levenes</surname><given-names>C</given-names></name>, <year>2014</year>
<article-title>Type 1 metabotropic glutamate
receptors (mGlu1) trigger the gating of GluD2 delta glutamate
receptors</article-title>. <source/>EMBO Rep. <volume>15</volume>,
<fpage>103</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">24357660</pub-id></mixed-citation>
</ref>
<ref id="R2">
<mixed-citation publication-type="journal"><name><surname>Benamer</surname><given-names>N</given-names></name>, <name><surname>Marti</surname><given-names>F</given-names></name>, <name><surname>Lujan</surname><given-names>R</given-names></name>, <name><surname>Hepp</surname><given-names>R</given-names></name>, <name><surname>Aubier</surname><given-names>TG</given-names></name>, <name><surname>Dupin</surname><given-names>AAM</given-names></name>, <name><surname>Frebourg</surname><given-names>G</given-names></name>, <name><surname>Pons</surname><given-names>S</given-names></name>, <name><surname>Maskos</surname><given-names>U</given-names></name>, <name><surname>Faure</surname><given-names>P</given-names></name>, <name><surname>Hay</surname><given-names>YA</given-names></name>, <name><surname>Lambolez</surname><given-names>B</given-names></name>, <name><surname>Tricoire</surname><given-names>L</given-names></name>, <year>2018</year>
<article-title>GluD1, linked to schizophrenia,
controls the burst firing of dopamine neurons</article-title>. <source/>Mol.
Psychiatry
<volume>23</volume> (<issue>3</issue>),
<fpage>691</fpage>–<lpage>700</lpage>.<pub-id pub-id-type="pmid">28696429</pub-id></mixed-citation>
</ref>
<ref id="R3">
<mixed-citation publication-type="journal"><name><surname>Bergles</surname><given-names>DE</given-names></name>, <name><surname>Roberts</surname><given-names>JD</given-names></name>, <name><surname>Somogyi</surname><given-names>P</given-names></name>, <name><surname>Jahr</surname><given-names>CE</given-names></name>, <year>2000</year>
<article-title>Glutamatergic synapses on
oligodendrocyte precursor cells in the hippocampus</article-title>.
<source/>Nature
<volume>405</volume>,
<fpage>187</fpage>–<lpage>191</lpage>.<pub-id pub-id-type="pmid">10821275</pub-id></mixed-citation>
</ref>
<ref id="R4">
<mixed-citation publication-type="journal"><name><surname>Bradfield</surname><given-names>LA</given-names></name>, <name><surname>Balleine</surname><given-names>BW</given-names></name>, <year>2017</year>
<article-title>Thalamic control of dorsomedial
striatum regulates internal state to guide goal-directed action
selection</article-title>. <source/>J. Neurosci
<volume>37</volume>,
<fpage>3721</fpage>–<lpage>3733</lpage>.<pub-id pub-id-type="pmid">28242795</pub-id></mixed-citation>
</ref>
<ref id="R5">
<mixed-citation publication-type="journal"><name><surname>Dang</surname><given-names>MT</given-names></name>, <name><surname>Yokoi</surname><given-names>F</given-names></name>, <name><surname>Yin</surname><given-names>HH</given-names></name>, <name><surname>Lovinger</surname><given-names>DM</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <year>2006</year>
<article-title>Disrupted motor learning and
long-term synaptic plasticity in mice lacking NMDAR1 in the
striatum</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A
<volume>103</volume>,
<fpage>15254</fpage>–<lpage>15259</lpage>.<pub-id pub-id-type="pmid">17015831</pub-id></mixed-citation>
</ref>
<ref id="R6">
<mixed-citation publication-type="journal"><name><surname>DeLong</surname><given-names>MR</given-names></name>, <name><surname>Wichmann</surname><given-names>T</given-names></name>, <year>2015</year>
<article-title>Basal ganglia circuits as targets for
neuromodulation in Parkinson disease</article-title>. <source/>JAMA
Neurol
<volume>72</volume>,
<fpage>1354</fpage>–<lpage>1360</lpage>.<pub-id pub-id-type="pmid">26409114</pub-id></mixed-citation>
</ref>
<ref id="R7">
<mixed-citation publication-type="journal"><name><surname>Dube</surname><given-names>L</given-names></name>, <name><surname>Smith</surname><given-names>AD</given-names></name>, <name><surname>Bolam</surname><given-names>JP</given-names></name>, <year>1988</year>
<article-title>Identification of synaptic terminals
of thalamic or cortical origin in contact with distinct medium-size spiny
neurons in the rat neostriatum</article-title>. <source/>J. Comp.
Neurol
<volume>267</volume>,
<fpage>455</fpage>–<lpage>471</lpage>.<pub-id pub-id-type="pmid">3346370</pub-id></mixed-citation>
</ref>
<ref id="R8">
<mixed-citation publication-type="journal"><name><surname>Edwards</surname><given-names>AC</given-names></name>, <name><surname>Aliev</surname><given-names>F</given-names></name>, <name><surname>Bierut</surname><given-names>LJ</given-names></name>, <name><surname>Bucholz</surname><given-names>KK</given-names></name>, <name><surname>Edenberg</surname><given-names>H</given-names></name>, <name><surname>Hesselbrock</surname><given-names>V</given-names></name>, <name><surname>Kramer</surname><given-names>J</given-names></name>, <name><surname>Kuperman</surname><given-names>S</given-names></name>, <name><surname>Nurnberger</surname><given-names>JI</given-names><suffix>Jr.</suffix></name>, <name><surname>Schuckit</surname><given-names>MA</given-names></name>, <name><surname>Porjesz</surname><given-names>B</given-names></name>, <name><surname>Dick</surname><given-names>DM</given-names></name>, <year>2012</year>
<article-title>Genome-wide association study of
comorbid depressive syndrome and alcohol dependence</article-title>.
<source/>Psychiatr. Genet
<volume>22</volume>,
<fpage>31</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">22064162</pub-id></mixed-citation>
</ref>
<ref id="R9">
<mixed-citation publication-type="journal"><name><surname>Ellender</surname><given-names>TJ</given-names></name>, <name><surname>Harwood</surname><given-names>J</given-names></name>, <name><surname>Kosillo</surname><given-names>P</given-names></name>, <name><surname>Capogna</surname><given-names>M</given-names></name>, <name><surname>Bolam</surname><given-names>JP</given-names></name>, <year>2013</year>
<article-title>Heterogeneous properties of central
lateral and parafascicular thalamic synapses in the
striatum</article-title>. <source/>J. Physiol
<volume>591</volume>,
<fpage>257</fpage>–<lpage>272</lpage>.<pub-id pub-id-type="pmid">23109111</pub-id></mixed-citation>
</ref>
<ref id="R10">
<mixed-citation publication-type="journal"><name><surname>Fallin</surname><given-names>MD</given-names></name>, <name><surname>Lasseter</surname><given-names>VK</given-names></name>, <name><surname>Avramopoulos</surname><given-names>D</given-names></name>, <name><surname>Nicodemus</surname><given-names>KK</given-names></name>, <name><surname>Wolyniec</surname><given-names>PS</given-names></name>, <name><surname>McGrath</surname><given-names>JA</given-names></name>, <name><surname>Steel</surname><given-names>G</given-names></name>, <name><surname>Nestadt</surname><given-names>G</given-names></name>, <name><surname>Liang</surname><given-names>KY</given-names></name>, <name><surname>Huganir</surname><given-names>RL</given-names></name>, <name><surname>Valle</surname><given-names>D</given-names></name>, <name><surname>Pulver</surname><given-names>AE</given-names></name>, <year>2005</year>
<article-title>Bipolar I disorder and schizophrenia:
a 440-single-nucleotide polymorphism screen of 64candidate genes among
Ashkenazi Jewish case-parent trios</article-title>. <source/>Am. J. Hum.
Genet
<volume>77</volume>,<fpage>918</fpage>–<lpage>936</lpage>.<pub-id pub-id-type="pmid">16380905</pub-id></mixed-citation>
</ref>
<ref id="R11">
<mixed-citation publication-type="journal"><name><surname>Fremeau</surname><given-names>RT</given-names><suffix>Jr.</suffix></name>, <name><surname>Troyer</surname><given-names>MD</given-names></name>, <name><surname>Pahner</surname><given-names>I</given-names></name>, <name><surname>Nygaard</surname><given-names>GO</given-names></name>, <name><surname>Tran</surname><given-names>CH</given-names></name>, <name><surname>Reimer</surname><given-names>RJ</given-names></name>, <name><surname>Bellocchio</surname><given-names>EE</given-names></name>, <name><surname>Fortin</surname><given-names>D</given-names></name>, <name><surname>Storm-Mathisen</surname><given-names>J</given-names></name>, <name><surname>Edwards</surname><given-names>RH</given-names></name>, <year>2001</year>
<article-title>The expression of vesicular glutamate
transporters defines two classes of excitatory synapse</article-title>.
<source/>Neuron
<volume>31</volume>,<fpage>247</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">11502256</pub-id></mixed-citation>
</ref>
<ref id="R12">
<mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Maison</surname><given-names>SF</given-names></name>, <name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Hirose</surname><given-names>K</given-names></name>, <name><surname>Jones</surname><given-names>SM</given-names></name>, <name><surname>Bayazitov</surname><given-names>I</given-names></name>, <name><surname>Tian</surname><given-names>Y</given-names></name>, <name><surname>Mittleman</surname><given-names>G</given-names></name>, <name><surname>Matthews</surname><given-names>DB</given-names></name>, <name><surname>Zakharenko</surname><given-names>SS</given-names></name>, <name><surname>Liberman</surname><given-names>MC</given-names></name>, <name><surname>Zuo</surname><given-names>J</given-names></name>, <year>2007</year>
<article-title>Orphan glutamate receptor delta1
subunit required for high-frequency hearing</article-title>. <source/>Mol.
Cell. Biol
<volume>27</volume>,
<fpage>4500</fpage>–<lpage>4512</lpage>.<pub-id pub-id-type="pmid">17438141</pub-id></mixed-citation>
</ref>
<ref id="R13">
<mixed-citation publication-type="journal"><name><surname>Glessner</surname><given-names>JT</given-names></name>, <name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Cai</surname><given-names>G</given-names></name>, <name><surname>Korvatska</surname><given-names>O</given-names></name>, <name><surname>Kim</surname><given-names>CE</given-names></name>, <name><surname>Wood</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Estes</surname><given-names>A</given-names></name>, <name><surname>Brune</surname><given-names>CW</given-names></name>, <name><surname>Bradfield</surname><given-names>JP</given-names></name>, <name><surname>Imielinski</surname><given-names>M</given-names></name>, <name><surname>Frackelton</surname><given-names>EC</given-names></name>, <name><surname>Reichert</surname><given-names>J</given-names></name>, <name><surname>Crawford</surname><given-names>EL</given-names></name>, <name><surname>Munson</surname><given-names>J</given-names></name>, <name><surname>Sleiman</surname><given-names>PM</given-names></name>, <name><surname>Chiavacci</surname><given-names>R</given-names></name>, <name><surname>Annaiah</surname><given-names>K</given-names></name>, <name><surname>Thomas</surname><given-names>K</given-names></name>, <name><surname>Hou</surname><given-names>C</given-names></name>, <name><surname>Glaberson</surname><given-names>W</given-names></name>, <name><surname>Flory</surname><given-names>J</given-names></name>, <name><surname>Otieno</surname><given-names>F</given-names></name>, <name><surname>Garris</surname><given-names>M</given-names></name>, <name><surname>Soorya</surname><given-names>L</given-names></name>, <name><surname>Klei</surname><given-names>L</given-names></name>, <name><surname>Piven</surname><given-names>J</given-names></name>, <name><surname>Meyer</surname><given-names>KJ</given-names></name>, <name><surname>Anagnostou</surname><given-names>E</given-names></name>, <name><surname>Sakurai</surname><given-names>T</given-names></name>, <name><surname>Game</surname><given-names>RM</given-names></name>, <name><surname>Rudd</surname><given-names>DS</given-names></name>, <name><surname>Zurawiecki</surname><given-names>D</given-names></name>, <name><surname>McDougle</surname><given-names>CJ</given-names></name>, <name><surname>Davis</surname><given-names>LK</given-names></name>, <name><surname>Miller</surname><given-names>J</given-names></name>, <name><surname>Posey</surname><given-names>DJ</given-names></name>, <name><surname>Michaels</surname><given-names>S</given-names></name>, <name><surname>Kolevzon</surname><given-names>A</given-names></name>, <name><surname>Silverman</surname><given-names>JM</given-names></name>, <name><surname>Bernier</surname><given-names>R</given-names></name>, <name><surname>Levy</surname><given-names>SE</given-names></name>, <name><surname>Schultz</surname><given-names>RT</given-names></name>, <name><surname>Dawson</surname><given-names>G</given-names></name>, <name><surname>Owley</surname><given-names>T</given-names></name>, <name><surname>McMahon</surname><given-names>WM</given-names></name>, <name><surname>Wassink</surname><given-names>TH</given-names></name>, <name><surname>Sweeney</surname><given-names>JA</given-names></name>, <name><surname>Nurnberger</surname><given-names>JI</given-names></name>, <name><surname>Coon</surname><given-names>H</given-names></name>, <name><surname>Sutcliffe</surname><given-names>JS</given-names></name>, <name><surname>Minshew</surname><given-names>NJ</given-names></name>, <name><surname>Grant</surname><given-names>SF</given-names></name>, <name><surname>Bucan</surname><given-names>M</given-names></name>, <name><surname>Cook</surname><given-names>EH</given-names></name>, <name><surname>Buxbaum</surname><given-names>JD</given-names></name>, <name><surname>Devlin</surname><given-names>B</given-names></name>, <name><surname>Schellenberg</surname><given-names>GD</given-names></name>, <name><surname>Hakonarson</surname><given-names>H</given-names></name>, <year>2009</year>
<article-title>Autism genome-wide copy number
variation reveals ubiquitin and neuronal genes</article-title>.
<source/>Nature
<volume>459</volume>,
<fpage>569</fpage>–<lpage>573</lpage>.<pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="R14">
<mixed-citation publication-type="journal"><name><surname>Greenwood</surname><given-names>TA</given-names></name>, <name><surname>Lazzeroni</surname><given-names>LC</given-names></name>, <name><surname>Murray</surname><given-names>SS</given-names></name>, <name><surname>Cadenhead</surname><given-names>KS</given-names></name>, <name><surname>Calkins</surname><given-names>ME</given-names></name>, <name><surname>Dobie</surname><given-names>DJ</given-names></name>, <name><surname>Green</surname><given-names>MF</given-names></name>, <name><surname>Gur</surname><given-names>RE</given-names></name>, <name><surname>Gur</surname><given-names>RC</given-names></name>, <name><surname>Hardiman</surname><given-names>G</given-names></name>, <name><surname>Kelsoe</surname><given-names>JR</given-names></name>, <name><surname>Leonard</surname><given-names>S</given-names></name>, <name><surname>Light</surname><given-names>GA</given-names></name>, <name><surname>Nuechterlein</surname><given-names>KH</given-names></name>, <name><surname>Olincy</surname><given-names>A</given-names></name>, <name><surname>Radant</surname><given-names>AD</given-names></name>, <name><surname>Schork</surname><given-names>NJ</given-names></name>, <name><surname>Seidman</surname><given-names>LJ</given-names></name>, <name><surname>Siever</surname><given-names>LJ</given-names></name>, <name><surname>Silverman</surname><given-names>JM</given-names></name>, <name><surname>Stone</surname><given-names>WS</given-names></name>, <name><surname>Swerdlow</surname><given-names>NR</given-names></name>, <name><surname>Tsuang</surname><given-names>DW</given-names></name>, <name><surname>Tsuang</surname><given-names>MT</given-names></name>, <name><surname>Turetsky</surname><given-names>BI</given-names></name>, <name><surname>Freedman</surname><given-names>R</given-names></name>, <name><surname>Braff</surname><given-names>DL</given-names></name>, <year>2011</year>
<article-title>Analysis of 94 candidate genes and 12
endophenotypes for schizophrenia from the consortium on the genetics of
schizophrenia</article-title>. <source/>Am. J. Psychiatry
<volume>168</volume>,
<fpage>930</fpage>–<lpage>946</lpage>.<pub-id pub-id-type="pmid">21498463</pub-id></mixed-citation>
</ref>
<ref id="R15">
<mixed-citation publication-type="journal"><name><surname>Griswold</surname><given-names>AJ</given-names></name>, <name><surname>Ma</surname><given-names>D</given-names></name>, <name><surname>Cukier</surname><given-names>HN</given-names></name>, <name><surname>Nations</surname><given-names>LD</given-names></name>, <name><surname>Schmidt</surname><given-names>MA</given-names></name>, <name><surname>Chung</surname><given-names>RH</given-names></name>, <name><surname>Jaworski</surname><given-names>JM</given-names></name>, <name><surname>Salyakina</surname><given-names>D</given-names></name>, <name><surname>Konidari</surname><given-names>I</given-names></name>, <name><surname>Whitehead</surname><given-names>PL</given-names></name>, <name><surname>Wright</surname><given-names>HH</given-names></name>, <name><surname>Abramson</surname><given-names>RK</given-names></name>,<name><surname>Williams</surname><given-names>SM</given-names></name>, <name><surname>Menon</surname><given-names>R</given-names></name>, <name><surname>Martin</surname><given-names>ER</given-names></name>, <name><surname>Haines</surname><given-names>JL</given-names></name>, <name><surname>Gilbert</surname><given-names>JR</given-names></name>, <name><surname>Cuccaro</surname><given-names>ML</given-names></name>, <name><surname>Pericak-Vance</surname><given-names>MA</given-names></name>, <year>2012</year>
<article-title>Evaluation of copy number variations
reveals novel candidate genes in autism spectrum disorder-associated
pathways</article-title>. <source/>Hum. Mol. Genet
<volume>21</volume>,
<fpage>3513</fpage>–<lpage>3523</lpage>.<pub-id pub-id-type="pmid">22543975</pub-id></mixed-citation>
</ref>
<ref id="R16">
<mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>SZ</given-names></name>, <name><surname>Huang</surname><given-names>K</given-names></name>, <name><surname>Shi</surname><given-names>YY</given-names></name>, <name><surname>Tang</surname><given-names>W</given-names></name>, <name><surname>Zhou</surname><given-names>J</given-names></name>, <name><surname>Feng</surname><given-names>GY</given-names></name>, <name><surname>Zhu</surname><given-names>SM</given-names></name>, <name><surname>Liu</surname><given-names>HJ</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>XD</given-names></name>, <name><surname>He</surname><given-names>L</given-names></name>, <year>2007</year>
<article-title>A case-control association study
between the GRID1 gene and schizophrenia in the Chinese northern Han
population</article-title>. <source/>Schizophr. Res
<volume>93</volume>,
<fpage>385</fpage>–<lpage>390</lpage>.<pub-id pub-id-type="pmid">17490860</pub-id></mixed-citation>
</ref>
<ref id="R17">
<mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>SC</given-names></name>, <name><surname>Yadav</surname><given-names>R</given-names></name>, <name><surname>Pavuluri</surname><given-names>R</given-names></name>, <name><surname>Morley</surname><given-names>BJ</given-names></name>, <name><surname>Stairs</surname><given-names>DJ</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <year>2015</year>
<article-title>Essential role of GluD1 in dendritic
spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex
and hippocampus reveals ability of GluN2B inhibition in correcting
hyperconnectivity</article-title>. <source/>Neuropharmacology
<volume>93</volume>,
<fpage>274</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">25721396</pub-id></mixed-citation>
</ref>
<ref id="R18">
<mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>SC</given-names></name>, <name><surname>Ravikrishnan</surname><given-names>A</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Mao</surname><given-names>Z</given-names></name>, <name><surname>Pavuluri</surname><given-names>R</given-names></name>, <name><surname>Hillman</surname><given-names>BG</given-names></name>, <name><surname>Gandhi</surname><given-names>PJ</given-names></name>, <name><surname>Stairs</surname><given-names>DJ</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Ugale</surname><given-names>RR</given-names></name>, <name><surname>Monaghan</surname><given-names>DT</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <year>2016</year>
<article-title>The NMDA receptor GluN2C subunit
controls cortical excitatory-inhibitory balance, neuronal oscillations and
cognitive function</article-title>. <source/>Sci. Rep
<volume>6</volume>, <fpage>38321</fpage>.<pub-id pub-id-type="pmid">27922130</pub-id></mixed-citation>
</ref>
<ref id="R19">
<mixed-citation publication-type="journal"><name><surname>Heinsen</surname><given-names>H</given-names></name>, <name><surname>Rub</surname><given-names>U</given-names></name>, <name><surname>Gangnus</surname><given-names>D</given-names></name>, <name><surname>Jungkunz</surname><given-names>G</given-names></name>, <name><surname>Bauer</surname><given-names>M</given-names></name>, <name><surname>Ulmar</surname><given-names>G</given-names></name>, <name><surname>Bethke</surname><given-names>B</given-names></name>, <name><surname>Schuler</surname><given-names>M</given-names></name>, <name><surname>Bocker</surname><given-names>F</given-names></name>, <name><surname>Eisenmenger</surname><given-names>W</given-names></name>, <name><surname>Gotz</surname><given-names>M</given-names></name>, <name><surname>Strik</surname><given-names>M</given-names></name>, <year>1996</year>
<article-title>Nerve cell loss in the thalamic
centromedian-parafascicular complex in patients with Huntington’s
disease</article-title>. <source/>Acta Neuropathol.
<volume>91</volume>,
<fpage>161</fpage>–<lpage>168</lpage>.<pub-id pub-id-type="pmid">8787149</pub-id></mixed-citation>
</ref>
<ref id="R20">
<mixed-citation publication-type="journal"><name><surname>Henderson</surname><given-names>JM</given-names></name>, <name><surname>Carpenter</surname><given-names>K</given-names></name>, <name><surname>Cartwright</surname><given-names>H</given-names></name>, <name><surname>Halliday</surname><given-names>GM</given-names></name>, <year>2000</year>
<article-title>Degeneration of the Centre
median-parafascicular complex in Parkinson’s disease</article-title>.
<source/>Ann. Neurol
<volume>47</volume>,
<fpage>345</fpage>–<lpage>352</lpage>.<pub-id pub-id-type="pmid">10716254</pub-id></mixed-citation>
</ref>
<ref id="R21">
<mixed-citation publication-type="journal"><name><surname>Hepp</surname><given-names>R</given-names></name>, <name><surname>Audrey Hay</surname><given-names>Y</given-names></name>, <name><surname>Aguado</surname><given-names>C</given-names></name>, <name><surname>Lujan</surname><given-names>R</given-names></name>, <name><surname>Dauphinot</surname><given-names>L</given-names></name>, <name><surname>Potier</surname><given-names>MC</given-names></name>, <name><surname>Nomura</surname><given-names>S</given-names></name>, <name><surname>Poirel</surname><given-names>O</given-names></name>, <name><surname>El Mestikawy</surname><given-names>S</given-names></name>, <name><surname>Lambolez</surname><given-names>B</given-names></name>, <name><surname>Tricoire</surname><given-names>L</given-names></name>, <year>2015</year>
<article-title>Glutamate receptors of the delta
family are widely expressed in the adult brain</article-title>.
<source/>Brain Struct. Funct
<volume>220</volume> (<issue>5</issue>),
<fpage>2797</fpage>–<lpage>2815</lpage>.<pub-id pub-id-type="pmid">25001082</pub-id></mixed-citation>
</ref>
<ref id="R22">
<mixed-citation publication-type="journal"><name><surname>Herkenham</surname><given-names>M</given-names></name>, <name><surname>Pert</surname><given-names>CB</given-names></name>, <year>1981</year>
<article-title>Mosaic distribution of opiate
receptors, parafascicular projections and acetylcholinesterase in rat
striatum</article-title>. <source/>Nature
<volume>291</volume>,
<fpage>415</fpage>–<lpage>418</lpage>.<pub-id pub-id-type="pmid">6165892</pub-id></mixed-citation>
</ref>
<ref id="R23">
<mixed-citation publication-type="journal"><name><surname>Iijima</surname><given-names>T</given-names></name>, <name><surname>Emi</surname><given-names>K</given-names></name>, <name><surname>Yuzaki</surname><given-names>M</given-names></name>, <year>2009</year>
<article-title>Activity-dependent repression of
Cbln1 expression: mechanism for developmental and homeostatic regulation of
synapses in the cerebellum</article-title>. <source/>J. Neurosci
<volume>29</volume>,
<fpage>5425</fpage>–<lpage>5434</lpage>.<pub-id pub-id-type="pmid">19403810</pub-id></mixed-citation>
</ref>
<ref id="R24">
<mixed-citation publication-type="journal"><name><surname>Iijima</surname><given-names>T</given-names></name>, <name><surname>Wu</surname><given-names>K</given-names></name>, <name><surname>Witte</surname><given-names>H</given-names></name>, <name><surname>Hanno-Iijima</surname><given-names>Y</given-names></name>, <name><surname>Glatter</surname><given-names>T</given-names></name>, <name><surname>Richard</surname><given-names>S</given-names></name>, <name><surname>Scheiffele</surname><given-names>P</given-names></name>, <year>2011</year>
<article-title>SAM68 regulates neuronal
activity-dependent alternative splicing of neurexin-1</article-title>.
<source/>Cell
<volume>147</volume>,
<fpage>1601</fpage>–<lpage>1614</lpage>.<pub-id pub-id-type="pmid">22196734</pub-id></mixed-citation>
</ref>
<ref id="R25">
<mixed-citation publication-type="journal"><name><surname>Kakegawa</surname><given-names>W</given-names></name>, <name><surname>Miyoshi</surname><given-names>Y</given-names></name>, <name><surname>Hamase</surname><given-names>K</given-names></name>, <name><surname>Matsuda</surname><given-names>S</given-names></name>, <name><surname>Matsuda</surname><given-names>K</given-names></name>, <name><surname>Kohda</surname><given-names>K</given-names></name>, <name><surname>Emi</surname><given-names>K</given-names></name>, <name><surname>Motohashi</surname><given-names>J</given-names></name>, <name><surname>Konno</surname><given-names>R</given-names></name>, <name><surname>Zaitsu</surname><given-names>K</given-names></name>, <name><surname>Yuzaki</surname><given-names>M</given-names></name>, <year>2011</year>
<article-title>D-serine regulates cerebellar LTD and
motor coordination through the delta2 glutamate receptor</article-title>.
<source/>Nat. Neurosci
<volume>14</volume>,<fpage>603</fpage>–<lpage>611</lpage>.<pub-id pub-id-type="pmid">21460832</pub-id></mixed-citation>
</ref>
<ref id="R26">
<mixed-citation publication-type="journal"><name><surname>Kashiwabuchi</surname><given-names>N</given-names></name>, <name><surname>Ikeda</surname><given-names>K</given-names></name>, <name><surname>Araki</surname><given-names>K</given-names></name>, <name><surname>Hirano</surname><given-names>T</given-names></name>, <name><surname>Shibuki</surname><given-names>K</given-names></name>, <name><surname>Takayama</surname><given-names>C</given-names></name>, <name><surname>Inoue</surname><given-names>Y</given-names></name>, <name><surname>Kutsuwada</surname><given-names>T</given-names></name>, <name><surname>Yagi</surname><given-names>T</given-names></name>, <name><surname>Kang</surname><given-names>Y</given-names></name>, <year>1995</year>
<article-title>Impairment of motor coordination,
Purkinje cell synapse formation, and cerebellar long-term depression in GluR
delta 2 mutant mice</article-title>. <source/>Cell
<volume>81</volume>,
<fpage>245</fpage>–<lpage>252</lpage>.<pub-id pub-id-type="pmid">7736576</pub-id></mixed-citation>
</ref>
<ref id="R27">
<mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>AS</given-names></name>, <name><surname>Knierman</surname><given-names>MD</given-names></name>, <name><surname>Siuda</surname><given-names>ER</given-names></name>, <name><surname>Isaac</surname><given-names>JT</given-names></name>, <name><surname>Nisenbaum</surname><given-names>ES</given-names></name>, <name><surname>Bredt</surname><given-names>DS</given-names></name>, <year>2012</year>
<article-title>Glutamatereceptor delta2 associates
with metabotropic glutamate receptor1 (mGluR1), protein kinase Cgamma, and
canonical transient receptor potential 3 and regulates mGluR1-mediated
synaptic transmission in cerebellar Purkinje neurons</article-title>.
<source/>J. Neurosci
<volume>32</volume>,
<fpage>15296</fpage>–<lpage>15308</lpage>.<pub-id pub-id-type="pmid">23115168</pub-id></mixed-citation>
</ref>
<ref id="R28">
<mixed-citation publication-type="journal"><name><surname>Konno</surname><given-names>K</given-names></name>, <name><surname>Matsuda</surname><given-names>K</given-names></name>, <name><surname>Nakamoto</surname><given-names>C</given-names></name>, <name><surname>Uchigashima</surname><given-names>M</given-names></name>, <name><surname>Miyazaki</surname><given-names>T</given-names></name>, <name><surname>Yamasaki</surname><given-names>M</given-names></name>, <name><surname>Sakimura</surname><given-names>K</given-names></name>, <name><surname>Yuzaki</surname><given-names>M</given-names></name>, <name><surname>Watanabe</surname><given-names>M</given-names></name>, <year>2014</year>
<article-title>Enriched expression of GluD1 in
higher brain regions and its involvement in parallelfiber-interneuron
synapse formation in the cerebellum</article-title>. <source/>J.
Neurosci
<volume>34</volume>,
<fpage>7412</fpage>–<lpage>7424</lpage>.<pub-id pub-id-type="pmid">24872547</pub-id></mixed-citation>
</ref>
<ref id="R29">
<mixed-citation publication-type="journal"><name><surname>Krauss</surname><given-names>JK</given-names></name>, <name><surname>Pohle</surname><given-names>T</given-names></name>, <name><surname>Weigel</surname><given-names>R</given-names></name>, <name><surname>Burgunder</surname><given-names>JM</given-names></name>, <year>2002</year>
<article-title>Deep brain stimulation of the Centre
median-parafascicular complex in patients with movement
disorders</article-title>. <source/>J. Neurol. Neurosurg. Psychiatry
<volume>72</volume>,
<fpage>546</fpage>–<lpage>548</lpage>.<pub-id pub-id-type="pmid">11909924</pub-id></mixed-citation>
</ref>
<ref id="R30">
<mixed-citation publication-type="journal"><name><surname>Kristensen</surname><given-names>AS</given-names></name>, <name><surname>Hansen</surname><given-names>KB</given-names></name>, <name><surname>Naur</surname><given-names>P</given-names></name>, <name><surname>Olsen</surname><given-names>L</given-names></name>, <name><surname>Kurtkaya</surname><given-names>NL</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <name><surname>Kvist</surname><given-names>T</given-names></name>, <name><surname>Yi</surname><given-names>F</given-names></name>, <name><surname>Pohlsgaard</surname><given-names>J</given-names></name>, <name><surname>Clausen</surname><given-names>RP</given-names></name>, <name><surname>Gajhede</surname><given-names>M</given-names></name>, <name><surname>Kastrup</surname><given-names>JS</given-names></name>, <name><surname>Traynelis</surname><given-names>SF</given-names></name>, <year>2016</year>
<article-title>Pharmacology and structural analysis
of ligand binding to the Orthosteric site of glutamate-like GluD2
receptors</article-title>. <source/>Mol. Pharmacol
<volume>89</volume>,
<fpage>253</fpage>–<lpage>262</lpage>.<pub-id pub-id-type="pmid">26661043</pub-id></mixed-citation>
</ref>
<ref id="R31">
<mixed-citation publication-type="journal"><name><surname>Larson</surname><given-names>VA</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Bergles</surname><given-names>DE</given-names></name>, <year>2016</year>
<article-title>Electrophysiological properties of
NG2(+) cells: matching physiological studies with gene expression
profiles</article-title>. <source/>Brain Res. <volume>1638</volume>,
<fpage>138</fpage>–<lpage>160</lpage>.<pub-id pub-id-type="pmid">26385417</pub-id></mixed-citation>
</ref>
<ref id="R32">
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Gandhi</surname><given-names>PJ</given-names></name>, <name><surname>Pavuluri</surname><given-names>R</given-names></name>, <name><surname>Shelkar</surname><given-names>GP</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <year>2018</year>
<article-title>Glutamate delta-1 receptor regulates
cocaine-induced plasticity in the nucleus accumbens</article-title>.
<source/>Transl. Psychiatry
<volume>8</volume>, <fpage>219
018</fpage>–<lpage>0273–9</lpage>.<pub-id pub-id-type="pmid">30315226</pub-id></mixed-citation>
</ref>
<ref id="R33">
<mixed-citation publication-type="journal"><name><surname>Livide</surname><given-names>G</given-names></name>, <name><surname>Patriarchi</surname><given-names>T</given-names></name>, <name><surname>Amenduni</surname><given-names>M</given-names></name>, <name><surname>Amabile</surname><given-names>S</given-names></name>, <name><surname>Yasui</surname><given-names>D</given-names></name>, <name><surname>Calcagno</surname><given-names>E</given-names></name>, <name><surname>Lo Rizzo</surname><given-names>C</given-names></name>, <name><surname>De Falco</surname><given-names>G</given-names></name>, <name><surname>Ulivieri</surname><given-names>C</given-names></name>, <name><surname>Ariani</surname><given-names>F</given-names></name>, <name><surname>Mari</surname><given-names>F</given-names></name>, <name><surname>Mencarelli</surname><given-names>MA</given-names></name>, <name><surname>Hell</surname><given-names>JW</given-names></name>, <name><surname>Renieri</surname><given-names>A</given-names></name>, <name><surname>Meloni</surname><given-names>I</given-names></name>, <year>2015</year>
<article-title>GluD1 is a common altered player in
neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS
cells</article-title>. <source/>Eur. J. Hum. Genet
<volume>23</volume>,
<fpage>195</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">24916645</pub-id></mixed-citation>
</ref>
<ref id="R34">
<mixed-citation publication-type="journal"><name><surname>Matsuda</surname><given-names>K</given-names></name>, <name><surname>Miura</surname><given-names>E</given-names></name>, <name><surname>Miyazaki</surname><given-names>T</given-names></name>, <name><surname>Kakegawa</surname><given-names>W</given-names></name>, <name><surname>Emi</surname><given-names>K</given-names></name>, <name><surname>Narumi</surname><given-names>S</given-names></name>, <name><surname>Fukazawa</surname><given-names>Y</given-names></name>, <name><surname>Ito-Ishida</surname><given-names>A</given-names></name>, <name><surname>Kondo</surname><given-names>T</given-names></name>, <name><surname>Shigemoto</surname><given-names>R</given-names></name>, <name><surname>Watanabe</surname><given-names>M</given-names></name>, <name><surname>Yuzaki</surname><given-names>M</given-names></name>, <year>2010</year>
<article-title>Cbln1 isa ligand for an orphan
glutamate receptor delta2, a bidirectional synapse
organizer</article-title>. <source/>Science
<volume>328</volume>,
<fpage>363</fpage>–<lpage>368</lpage>.<pub-id pub-id-type="pmid">20395510</pub-id></mixed-citation>
</ref>
<ref id="R35">
<mixed-citation publication-type="journal"><name><surname>Miura</surname><given-names>E</given-names></name>, <name><surname>Iijima</surname><given-names>T</given-names></name>, <name><surname>Yuzaki</surname><given-names>M</given-names></name>, <name><surname>Watanabe</surname><given-names>M</given-names></name>, <year>2006</year>
<article-title>Distinct expression of Cbln family
mRNAs in developing and adult mouse brains</article-title>. <source/>Eur. J.
Neurosci
<volume>24</volume>,
<fpage>750</fpage>–<lpage>760</lpage>.<pub-id pub-id-type="pmid">16930405</pub-id></mixed-citation>
</ref>
<ref id="R36">
<mixed-citation publication-type="journal"><name><surname>Naur</surname><given-names>P</given-names></name>, <name><surname>Hansen</surname><given-names>KB</given-names></name>, <name><surname>Kristensen</surname><given-names>AS</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <name><surname>Pickering</surname><given-names>DS</given-names></name>, <name><surname>Olsen</surname><given-names>L</given-names></name>, <name><surname>Vestergaard</surname><given-names>B</given-names></name>, <name><surname>Egebjerg</surname><given-names>J</given-names></name>, <name><surname>Gajhede</surname><given-names>M</given-names></name>, <name><surname>Traynelis</surname><given-names>SF</given-names></name>, <name><surname>Kastrup</surname><given-names>JS</given-names></name>, <year>2007</year>
<article-title>Ionotropic glutamate-like receptor
delta2 binds D-serine and glycine</article-title>. <source/>Proc. Natl. Acad.
Sci. U. S. A
<volume>104</volume>,
<fpage>14116</fpage>–<lpage>14121</lpage>.<pub-id pub-id-type="pmid">17715062</pub-id></mixed-citation>
</ref>
<ref id="R37">
<mixed-citation publication-type="journal"><name><surname>Nord</surname><given-names>AS</given-names></name>, <name><surname>Roeb</surname><given-names>W</given-names></name>, <name><surname>Dickel</surname><given-names>DE</given-names></name>, <name><surname>Walsh</surname><given-names>T</given-names></name>, <name><surname>Kusenda</surname><given-names>M</given-names></name>,<name><surname>O’Connor</surname><given-names>KL</given-names></name>, <name><surname>Malhotra</surname><given-names>D</given-names></name>, <name><surname>McCarthy</surname><given-names>SE</given-names></name>, <name><surname>Stray</surname><given-names>SM</given-names></name>, <name><surname>Taylor</surname><given-names>SM</given-names></name>, <name><surname>Sebat</surname><given-names>J</given-names></name>, <collab>STAART Psychopharmacology Network</collab>, <name><surname>King</surname><given-names>B</given-names></name>, <name><surname>King</surname><given-names>MC</given-names></name>, <name><surname>McClellan</surname><given-names>JM</given-names></name>, <year>2011</year>
<article-title>Reduced transcript expression of
genesaffected by inherited and de novo CNVs in autism</article-title>.
<source/>Eur. J. Hum. Genet
<volume>19</volume>,
<fpage>727</fpage>–<lpage>731</lpage>.<pub-id pub-id-type="pmid">21448237</pub-id></mixed-citation>
</ref>
<ref id="R38">
<mixed-citation publication-type="journal"><name><surname>Otsuka</surname><given-names>S</given-names></name>, <name><surname>Konno</surname><given-names>K</given-names></name>, <name><surname>Abe</surname><given-names>M</given-names></name>, <name><surname>Motohashi</surname><given-names>J</given-names></name>, <name><surname>Kohda</surname><given-names>K</given-names></name>, <name><surname>Sakimura</surname><given-names>K</given-names></name>, <name><surname>Watanabe</surname><given-names>M</given-names></name>, <name><surname>Yuzaki</surname><given-names>M</given-names></name>, <year>2016</year>
<article-title>Roles of Cbln1 in non-motor functions
of mice</article-title>. <source/>J. Neurosci
<volume>36</volume>,
<fpage>11801</fpage>–<lpage>11816</lpage>.<pub-id pub-id-type="pmid">27852787</pub-id></mixed-citation>
</ref>
<ref id="R39">
<mixed-citation publication-type="journal"><name><surname>Parker</surname><given-names>PR</given-names></name>, <name><surname>Lalive</surname><given-names>AL</given-names></name>, <name><surname>Kreitzer</surname><given-names>AC</given-names></name>, <year>2016</year>
<article-title>Pathway-specific remodeling of
thalamostriatal synapses in Parkinsonian mice</article-title>.
<source/>Neuron
<volume>89</volume>,
<fpage>734</fpage>–<lpage>740</lpage>.<pub-id pub-id-type="pmid">26833136</pub-id></mixed-citation>
</ref>
<ref id="R40">
<mixed-citation publication-type="journal"><name><surname>Parr-Brownlie</surname><given-names>LC</given-names></name>, <name><surname>Poloskey</surname><given-names>SL</given-names></name>, <name><surname>Bergstrom</surname><given-names>DA</given-names></name>, <name><surname>Walters</surname><given-names>JR</given-names></name>, <year>2009</year>
<article-title>Parafascicular thalamic nucleus
activity in a rat model of Parkinson’s disease</article-title>.
<source/>Exp. Neurol
<volume>217</volume>,
<fpage>269</fpage>–<lpage>281</lpage>.<pub-id pub-id-type="pmid">19268664</pub-id></mixed-citation>
</ref>
<ref id="R41">
<mixed-citation publication-type="journal"><name><surname>Patriarchi</surname><given-names>T</given-names></name>, <name><surname>Amabile</surname><given-names>S</given-names></name>, <name><surname>Frullanti</surname><given-names>E</given-names></name>, <name><surname>Landucci</surname><given-names>E</given-names></name>, <name><surname>Lo Rizzo</surname><given-names>C</given-names></name>, <name><surname>Ariani</surname><given-names>F</given-names></name>, <name><surname>Costa</surname><given-names>M</given-names></name>, <name><surname>Olimpico</surname><given-names>F</given-names></name>, <name><surname>W Hell</surname><given-names>J</given-names></name>, <name><surname>M Vaccarino</surname><given-names>F</given-names></name>, <name><surname>Renieri</surname><given-names>A</given-names></name>, <name><surname>Meloni</surname><given-names>I</given-names></name>, <year>2016</year>
<article-title>Imbalance of excitatory/inhibitory
synaptic protein expression in iPSC-derived neurons from
FOXG1(+/−)patients and in foxg1(+/−)mice</article-title>.
<source/>Eur. J. Hum. Genet
<volume>24</volume>,<fpage>871</fpage>–<lpage>880</lpage>.<pub-id pub-id-type="pmid">26443267</pub-id></mixed-citation>
</ref>
<ref id="R42">
<mixed-citation publication-type="journal"><name><surname>Raju</surname><given-names>DV</given-names></name>, <name><surname>Shah</surname><given-names>DJ</given-names></name>, <name><surname>Wright</surname><given-names>TM</given-names></name>, <name><surname>Hall</surname><given-names>RA</given-names></name>, <name><surname>Smith</surname><given-names>Y</given-names></name>, <year>2006</year>
<article-title>Differential synaptology of
vGluT2-containing thalamostriatalafferents between the patch and matrix
compartments in rats</article-title>. <source/>J. Comp. Neurol
<volume>499</volume>,
<fpage>231</fpage>–<lpage>243</lpage>.<pub-id pub-id-type="pmid">16977615</pub-id></mixed-citation>
</ref>
<ref id="R43">
<mixed-citation publication-type="journal"><name><surname>Rothwell</surname><given-names>PE</given-names></name>, <name><surname>Fuccillo</surname><given-names>MV</given-names></name>, <name><surname>Maxeiner</surname><given-names>S</given-names></name>, <name><surname>Hayton</surname><given-names>SJ</given-names></name>, <name><surname>Gokce</surname><given-names>O</given-names></name>, <name><surname>Lim</surname><given-names>BK</given-names></name>, <name><surname>Fowler</surname><given-names>SC</given-names></name>, <name><surname>Malenka</surname><given-names>RC</given-names></name>, <name><surname>Sudhof</surname><given-names>TC</given-names></name>, <year>2014</year>
<article-title>Autism-associated neuroligin-3
mutations commonly impair striatal circuits to boost repetitive
behaviors</article-title>. <source/>Cell
<volume>158</volume>,
<fpage>198</fpage>–<lpage>212</lpage>.<pub-id pub-id-type="pmid">24995986</pub-id></mixed-citation>
</ref>
<ref id="R44">
<mixed-citation publication-type="journal"><name><surname>Sadikot</surname><given-names>AF</given-names></name>, <name><surname>Parent</surname><given-names>A</given-names></name>, <name><surname>Smith</surname><given-names>Y</given-names></name>, <name><surname>Bolam</surname><given-names>JP</given-names></name>, <year>1992</year><article-title>Efferent connections of the
centromedian and parafascicular thalamic nuclei in the squirrel monkey: a
light and electron microscopic study of the thalamostriatal projection in
relation to striatal heterogeneity</article-title>. <source/>J. Comp.
Neurol
<volume>320</volume>,
<fpage>228</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">1619051</pub-id></mixed-citation>
</ref>
<ref id="R45">
<mixed-citation publication-type="journal"><name><surname>Saunders</surname><given-names>A</given-names></name>, <name><surname>Macosko</surname><given-names>EZ</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Goldman</surname><given-names>M</given-names></name>, <name><surname>Krienen</surname><given-names>FM</given-names></name>, <name><surname>de Rivera</surname><given-names>H</given-names></name>, <name><surname>Bien</surname><given-names>E</given-names></name>, <name><surname>Baum</surname><given-names>M</given-names></name>, <name><surname>Bortolin</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Goeva</surname><given-names>A</given-names></name>, <name><surname>Nemesh</surname><given-names>J</given-names></name>, <name><surname>Kamitaki</surname><given-names>N</given-names></name>, <name><surname>Brumbaugh</surname><given-names>S</given-names></name>, <name><surname>Kulp</surname><given-names>D</given-names></name>, <name><surname>McCarroll</surname><given-names>SA</given-names></name>, <year>2018</year>
<article-title>Molecular diversity and
specializations among the cells of the adult mouse brain</article-title>.
<source/>Cell
<volume>174</volume>,
<fpage>1015</fpage>–<lpage>1030.e16</lpage>.<pub-id pub-id-type="pmid">30096299</pub-id></mixed-citation>
</ref>
<ref id="R46">
<mixed-citation publication-type="journal"><name><surname>Sharma</surname><given-names>VD</given-names></name>, <name><surname>Mewes</surname><given-names>K</given-names></name>, <name><surname>Wichmann</surname><given-names>T</given-names></name>, <name><surname>Buetefisch</surname><given-names>C</given-names></name>, <name><surname>Willie</surname><given-names>JT</given-names></name>, <name><surname>DeLong</surname><given-names>M</given-names></name>, <year>2017</year>
<article-title>Deep brain stimulation of the
centromedian thalamic nucleus for essential tremor:a case
report</article-title>. <source/>Acta Neurochir.
<volume>159</volume>,
<fpage>789</fpage>–<lpage>793</lpage>.<pub-id pub-id-type="pmid">28303332</pub-id></mixed-citation>
</ref>
<ref id="R47">
<mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>M</given-names></name>, <name><surname>Spence</surname><given-names>MA</given-names></name>, <name><surname>Flodman</surname><given-names>P</given-names></name>, <year>2009</year>
<article-title>Nuclear and mitochondrial genome
defects in autisms</article-title>. <source/>Ann. N. Y. Acad. Sci
<volume>1151</volume>,
<fpage>102</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">19154520</pub-id></mixed-citation>
</ref>
<ref id="R48">
<mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>Y</given-names></name>, <name><surname>Galvan</surname><given-names>A</given-names></name>, <name><surname>Ellender</surname><given-names>TJ</given-names></name>, <name><surname>Doig</surname><given-names>N</given-names></name>, <name><surname>Villalba</surname><given-names>RM</given-names></name>, <name><surname>Huerta-Ocampo</surname><given-names>I</given-names></name>, <name><surname>Wichmann</surname><given-names>T</given-names></name>, <name><surname>Bolam</surname><given-names>JP</given-names></name>, <year>2014</year>
<article-title>The thalamostriatal system in normal
and diseased states</article-title>. <source/>Front. Syst. Neurosci
<volume>8</volume>,<fpage>5</fpage>.<pub-id pub-id-type="pmid">24523677</pub-id></mixed-citation>
</ref>
<ref id="R49">
<mixed-citation publication-type="journal"><name><surname>Sudhof</surname><given-names>TC</given-names></name>, <year>2017</year>
<article-title>Synaptic Neurexin complexes: a
molecular code for the logic of neural circuits</article-title>.
<source/>Cell
<volume>171</volume>,
<fpage>745</fpage>–<lpage>769</lpage>.<pub-id pub-id-type="pmid">29100073</pub-id></mixed-citation>
</ref>
<ref id="R50">
<mixed-citation publication-type="journal"><name><surname>Suryavanshi</surname><given-names>PS</given-names></name>, <name><surname>Gupta</surname><given-names>SC</given-names></name>, <name><surname>Yadav</surname><given-names>R</given-names></name>, <name><surname>Kesherwani</surname><given-names>V</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <year>2016</year>
<article-title>Glutamate Delta-1 receptor regulates
metabotropic glutamate receptor 5 Signaling in the
Hippocampus</article-title>. <source/>Mol. Pharmacol
<volume>90</volume>,
<fpage>96</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">27231330</pub-id></mixed-citation>
</ref>
<ref id="R51">
<mixed-citation publication-type="journal"><name><surname>Treutlein</surname><given-names>J</given-names></name>, <name><surname>Muhleisen</surname><given-names>TW</given-names></name>, <name><surname>Frank</surname><given-names>J</given-names></name>, <name><surname>Mattheisen</surname><given-names>M</given-names></name>, <name><surname>Herms</surname><given-names>S</given-names></name>, <name><surname>Ludwig</surname><given-names>KU</given-names></name>, <name><surname>Treutlein</surname><given-names>T</given-names></name>, <name><surname>Schmael</surname><given-names>C</given-names></name>, <name><surname>Strohmaier</surname><given-names>J</given-names></name>, <name><surname>Bosshenz</surname><given-names>KV</given-names></name>, <name><surname>Breuer</surname><given-names>R</given-names></name>, <name><surname>Paul</surname><given-names>T</given-names></name>, <name><surname>Witt</surname><given-names>SH</given-names></name>, <name><surname>Schulze</surname><given-names>TG</given-names></name>, <name><surname>Schlosser</surname><given-names>RG</given-names></name>, <name><surname>Nenadic</surname><given-names>I</given-names></name>, <name><surname>Sauer</surname><given-names>H</given-names></name>, <name><surname>Becker</surname><given-names>T</given-names></name>, <name><surname>Maier</surname><given-names>W</given-names></name>, <name><surname>Cichon</surname><given-names>S</given-names></name>, <name><surname>Nothen</surname><given-names>MM</given-names></name>, <name><surname>Rietschel</surname><given-names>M</given-names></name>, <year>2009</year>
<article-title>Dissection of phenotype reveals
possible association between schizophrenia and glutamate Receptor Delta 1
(GRID1) gene promoter</article-title>. <source/>Schizophr. Res
<volume>111</volume>,
<fpage>123</fpage>–<lpage>130</lpage>.<pub-id pub-id-type="pmid">19346103</pub-id></mixed-citation>
</ref>
<ref id="R52">
<mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>TN</given-names></name>, <name><surname>Yi</surname><given-names>Q</given-names></name>, <name><surname>Krumm</surname><given-names>N</given-names></name>, <name><surname>Huddleston</surname><given-names>J</given-names></name>, <name><surname>Hoekzema</surname><given-names>K</given-names></name>, <name><surname>F Stessman</surname><given-names>HA</given-names></name>, <name><surname>Doebley</surname><given-names>AL</given-names></name>, <name><surname>Bernier</surname><given-names>RA</given-names></name>, <name><surname>Nickerson</surname><given-names>DA</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name>, <year>2017</year>
<article-title>Denovo-Db:a compendium of human De
novo variants</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>,
<fpage>D804</fpage>–<lpage>D811</lpage>.<pub-id pub-id-type="pmid">27907889</pub-id></mixed-citation>
</ref>
<ref id="R53">
<mixed-citation publication-type="journal"><name><surname>Uemura</surname><given-names>T</given-names></name>, <name><surname>Mori</surname><given-names>H</given-names></name>, <name><surname>Mishina</surname><given-names>M</given-names></name>, <year>2004</year>
<article-title>Direct interaction of GluRdelta2 with
shank scaffold proteins in cerebellar Purkinje cells</article-title>.
<source/>Mol. Cell. Neurosci
<volume>26</volume>,
<fpage>330</fpage>–<lpage>341</lpage>.<pub-id pub-id-type="pmid">15207857</pub-id></mixed-citation>
</ref>
<ref id="R54">
<mixed-citation publication-type="journal"><name><surname>Uemura</surname><given-names>T</given-names></name>, <name><surname>Lee</surname><given-names>SJ</given-names></name>, <name><surname>Yasumura</surname><given-names>M</given-names></name>, <name><surname>Takeuchi</surname><given-names>T</given-names></name>, <name><surname>Yoshida</surname><given-names>T</given-names></name>, <name><surname>Ra</surname><given-names>M</given-names></name>, <name><surname>Taguchi</surname><given-names>R</given-names></name>, <name><surname>Sakimura</surname><given-names>K</given-names></name>, <name><surname>Mishina</surname><given-names>M</given-names></name>, <year>2010</year>
<article-title>Trans-synaptic interaction of
GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the
cerebellum</article-title>. <source/>Cell
<volume>141</volume>,
<fpage>1068</fpage>–<lpage>1079</lpage>.<pub-id pub-id-type="pmid">20537373</pub-id></mixed-citation>
</ref>
<ref id="R55">
<mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>P</given-names></name>, <name><surname>Pattarini</surname><given-names>R</given-names></name>, <name><surname>Rong</surname><given-names>Y</given-names></name>, <name><surname>Guo</surname><given-names>H</given-names></name>, <name><surname>Bansal</surname><given-names>PK</given-names></name>, <name><surname>Kusnoor</surname><given-names>SV</given-names></name>, <name><surname>Deutch</surname><given-names>AY</given-names></name>, <name><surname>Parris</surname><given-names>J</given-names></name>, <name><surname>Morgan</surname><given-names>JI</given-names></name>, <year>2012</year>
<article-title>The Cbln family of proteins interact
with multiple signaling pathways</article-title>. <source/>J.
Neurochem
<volume>121</volume>,
<fpage>717</fpage>–<lpage>729</lpage>.<pub-id pub-id-type="pmid">22220752</pub-id></mixed-citation>
</ref>
<ref id="R56">
<mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>YW</given-names></name>, <name><surname>Kim</surname><given-names>JI</given-names></name>, <name><surname>Tawfik</surname><given-names>VL</given-names></name>, <name><surname>Lalchandani</surname><given-names>RR</given-names></name>, <name><surname>Scherrer</surname><given-names>G</given-names></name>, <name><surname>Ding</surname><given-names>JB</given-names></name>, <year>2015</year>
<article-title>Inputand cell-type-specific
endocannabinoid-dependent LTD in the striatum</article-title>. <source/>Cell
Rep. <volume>10</volume>,
<fpage>75</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">25543142</pub-id></mixed-citation>
</ref>
<ref id="R57">
<mixed-citation publication-type="journal"><name><surname>Yadav</surname><given-names>R</given-names></name>, <name><surname>Rimerman</surname><given-names>R</given-names></name>, <name><surname>Scofield</surname><given-names>MA</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <year>2011</year>
<article-title>Mutations in the transmembrane domain
M3 generate spontaneously open orphan glutamate delta1
receptor</article-title>. <source/>Brain Res.
<volume>1382</volume>,<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">21215726</pub-id></mixed-citation>
</ref>
<ref id="R58">
<mixed-citation publication-type="journal"><name><surname>Yadav</surname><given-names>R</given-names></name>, <name><surname>Gupta</surname><given-names>SC</given-names></name>, <name><surname>Hillman</surname><given-names>BG</given-names></name>, <name><surname>Bhatt</surname><given-names>JM</given-names></name>, <name><surname>Stairs</surname><given-names>DJ</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <year>2012</year>
<article-title>Deletion of glutamate delta-1
receptor in mouse leads to aberrant emotional and social
behaviors</article-title>. <source/>PLoS One
<volume>7</volume>, <fpage>e32969</fpage>.<pub-id pub-id-type="pmid">22412961</pub-id></mixed-citation>
</ref>
<ref id="R59">
<mixed-citation publication-type="journal"><name><surname>Yadav</surname><given-names>R</given-names></name>, <name><surname>Hillman</surname><given-names>BG</given-names></name>, <name><surname>Gupta</surname><given-names>SC</given-names></name>, <name><surname>Suryavanshi</surname><given-names>P</given-names></name>, <name><surname>Bhatt</surname><given-names>JM</given-names></name>, <name><surname>Pavuluri</surname><given-names>R</given-names></name>, <name><surname>Stairs</surname><given-names>DJ</given-names></name>, <name><surname>Dravid</surname><given-names>SM</given-names></name>, <year>2013</year>
<article-title>Deletion of glutamate delta-1
receptor in mouse leads to enhanced working memory and deficit in fear
conditioning</article-title>. <source/>PLoS One
<volume>8</volume>, <fpage>e60785</fpage>.<pub-id pub-id-type="pmid">23560106</pub-id></mixed-citation>
</ref>
<ref id="R60">
<mixed-citation publication-type="journal"><name><surname>Yuzaki</surname><given-names>M</given-names></name>, <year>2018</year>
<article-title>Two classes of secreted synaptic
organizers in the central nervous system</article-title>. <source/>Annu. Rev.
Physiol
<volume>80</volume>,
<fpage>243</fpage>–<lpage>262</lpage>.<pub-id pub-id-type="pmid">29166241</pub-id></mixed-citation>
</ref>
<ref id="R61">
<mixed-citation publication-type="journal"><name><surname>Yuzaki</surname><given-names>M</given-names></name>, <name><surname>Aricescu</surname><given-names>AR</given-names></name>, <year>2017</year>
<article-title>A GluD coming-of-age
story</article-title>. <source/>Trends Neurosci.
<volume>40</volume>,
<fpage>138</fpage>–<lpage>150</lpage>.<pub-id pub-id-type="pmid">28110935</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Fig. 1.</label>
<caption>
<p id="P42">Deletion of GluD1 from the striatum but not corticolimbic region impairs
behavioral flexibility. A. Strategy for deletion of GluD1 from corticolimbic
region. BB’. No significant difference was observed in the number of
percent trials without errors across days during habit acquisition (genotype [F
(1, 11) = 0.7664, <italic>p</italic> = .4000)], Two-way repeated measures ANOVA)
or latency to find the platform (genotype [F (1, 11) = 0.1618,
<italic>p</italic> = .6952)]) (<italic>N</italic> = 6 for WT and
<italic>N</italic> = 8 for Corticolimbic (CL)-GluD1 KO).
B″-B”‘. No significant differences were observed in total
errors (genotype [F (1, 11) = 0.9646, <italic>p</italic> = .3471]) or
preservative errors (genotype [F (1, 11) = 1.35, <italic>p</italic> = .2699])
during the reversal learning in corticolimbic-GluD1 KO. C. In the rotarod test,
during test phase no significant difference in the latency to fall was observed
in WT and CL-GluD1 KO mice (N = 11 for WT and N = 10 for CL-GluD1 KO; Two-way
repeated measures ANOVA genotype [F (1, 19) = 1.402, <italic>p</italic> =
.2511)], trials [F (5, 95) = 10.3, <italic>p</italic> &lt; .0001)] and
interaction [F (5, 95) = 0.2416, <italic>p</italic> = .9430]). D. In the open
field test, no significant difference was found between WT and CL-GluD1 KO mice
in total distance traveled (N = 10 for WT and N = 14 for CL-GluD1 KO; WT 39.44
± 2.71, vs CL-GluD1 KO 43.96 ± 1.538, <italic>p</italic> = .1683,
unpaired <italic>t</italic>-test). E. Strategy to deletion of GluD1 from
striatal neurons. F. Mice were tested in water T-maze test. No significant
difference was observed in the percent trials without errors on training days
between the two groups (N = 12 for WT and N = 14 for St-GluD1 KO). F′.
The latency to reach the platform during the training phase was significantly
shorter in St-GluD1 KO. Two-way repeated measures ANOVA revealed a significant
effect of genotype [F (1, 24) = 6.236, <italic>p</italic> = .0198)] and time [F
(7, 168) = 15.35, <italic>p</italic> &lt; .0001)] on latency to find
platform. Bonferroni’s post-hoc test revealed a significant reduction in
latency to find platform in the St-GluD1 KO mice (day 2: <italic>p</italic> =
.0107). F″. In the reversal learning test St-GluD1 KO mice made
significantly more total errors across days. Comparison of errors in all ten
trials for each day was conducted by two-way repeated measures ANOVA which
revealed a significant effect of genotype [F (1, 24) = 31.21, <italic>p</italic>
&lt; .0001)], time [F (5, 120) = 151.9, <italic>p</italic> &lt; .0001)]
and interaction [F (5,120) = 18.19, <italic>p</italic> &lt; .0001 on total
errors. Bonferroni’s post-hoc test revealed a significantly higher number
of total errors in the St-GluD1 KO mice (day 1: <italic>p</italic> ≤
.0001). F″’. St-GluD1 KO mice made more perseverative errors.
Comparison of total preservative errors per day across days by two-way repeated
measures ANOVA revealed a significant effect of genotype [F (1, 24) = 16.93,
<italic>p</italic> = .0004)], time [F (5, 120) = 167.5, <italic>p</italic>
&lt; .0001)] and interaction [F (5,120) = 12.59, <italic>p</italic> &lt;
.0001] on total preservative errors. Bonferroni’s post-hoc test revealed
a significantly higher number of total errors in the St-GluD1 KO mice (day 1:
<italic>p</italic> &lt; .0001; day 2: <italic>p</italic> = .0105). All
data are presented as mean ± SEM. G. In the rotarod test, the latency to
fall during test phases was longer in St-GluD1 KO mice than WT
(<italic>N</italic> = 13 for WT and <italic>N</italic> = 17 for St-GluD1
KO). Two-way repeated measures ANOVA revealed a significant effect of genotype
[F (1, 28) = 9.190, <italic>p</italic> = .0052)], trials [F (5, 140) = 13.55,
<italic>p</italic> &lt; .0001)] and interaction [F (5, 140) = 0.4604,
<italic>p</italic> = .8052] on falling latency. Bonferroni’s post-hoc
test revealed a significant difference in falling latency of St-GluD1 KO mice
(trial 2 WT 68.36 ± 6.722 vs St-GluD1 KO 101.6 ± 8.405:
<italic>p</italic> = .0270; trial 4 WT 74.47 ± 7.464 vs St-GluD1 KO
105.7 ± 9.552: <italic>p</italic> = .0458; trial 6 WT 74.85 ±
8.605 vs St-GluD1 KO 108.0 ± 8.649: <italic>p</italic> = .0275). H. In
the open field test, no significant difference was found between WT and St-GluD1
KO mice in total distance traveled (N = 13 for WT and N = 17 for St-GluD1 KO; WT
30.65 ± 2.405 vs St-GluD1 KO 37.39 ± 2.442, <italic>p</italic> =
.0641, unpaired <italic>t</italic>-test).</p>
</caption>
<graphic xlink:href="nihms-1551653-f0001"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Fig. 2.</label>
<caption>
<p id="P43">GluD1 in the dorsal striatum controls behavioral flexibility. A.
Strategy for local ablation of GluD1 from dorsal striatum. AAV-eGFP or
AAV-eGFP-Cre were stereotaxically injected into the dorsal striatum of
GluD1<sup>flox/flox</sup> mice. B. Striatal AAV-eGFP and AAV-eGFP-Cre mice
did not show any significant change in the percent trials without errors on
training days (<italic>N</italic> = 7 for AAV-eGFP and 7 for AAV-eGFP-Cre).
B′. The latency to reach the platform during the training (habit
acquisition) phase was shorter in AAV-eGFP-Cre compared to the AAV-eGFP group.
Two-way repeated measures ANOVA treatment [F (1, 12) = 13.95, <italic>p</italic>
= .0029)], days [F (6, 72) = 5.064, <italic>p</italic> &lt; .0002)] and
interaction [F (6, 72) = 0.5384, <italic>p</italic> = .7773. Post-hoc
Bonferroni’s test revealed significance at day 2: AAV-eGFP 32.24 ±
4.718 vs. AAV-eGFP-Cre 14.53 ± 2.878, <italic>p</italic> = .0343; day 5:
AAV-eGFP 24.16 ± 2.635, vs. AAV-eGFP-Cre 12.16 ± 1.96,
<italic>p</italic> = .0279; day 6: AAV-eGFP 19.64 ± 2.532, vs
AAV-eGFP-Cre 7.814 ± 1.729, <italic>p</italic> = .0316. B″. During
reversal learning test, AAV-eGFP-Cre mice made significantly more total errors
compared to AAV-eGFP group. Two-way repeated measures ANOVA treatment [F (1, 12)
= 19.05, <italic>p</italic> = .0009)], days [F (5, 60) = 18.49,
<italic>p</italic> &lt; .0001)] and interaction [F (5, 60) = 3.057,
<italic>p</italic> = .0160]. Bonferroni’s post-hoc test revealed
significance on day 1 (AAV-eGFP 7.571 ± 0.4809 vs. AAV-eGFP-Cre 17.29
± 4.932, <italic>p</italic> &lt; .0002); day 2 (AAV-eGFP 0.8571
± 0.3401 vs. AAV-eGFP-Cre 7.429 ± 1.11, <italic>p</italic>
&lt; .0220). B″’. Similarly, AAV-eGFP-Cre committed more
number of perseverative errors compared to AAV-eGFP group. Two-way repeated
measures ANOVA treatment [F (1, 12) = 31.69, <italic>p</italic> = .0001)], days
[F (5, 60) = 28.2, <italic>p</italic> &lt; .0001)] and interaction [F (5,
60) = 5.064, <italic>p</italic> = .0006]. Bonferroni’s post-hoc test
revealed significance on day 1 (AAV-eGFP 6.429 ± 0.8411 vs AAV-eGFP-Cre
14.14 ± 2.874, <italic>p</italic> &lt; .0001); day 2 (AAV-eGFP 0.5714
± 0.2974 vs AAV-eGFP-Cre 7.429 ± 1.11, <italic>p</italic> &lt;
.0001). C. In the rotarod test, the latency to fall during test phase was longer
in AAV-eGFP-Cre than AAV-eGFP injected mice (N = 14 for AAV-eGFP and N = 13 for
AAV-eGFP-Cre). Two-way repeated measures ANOVA revealed a significant effect of
genotype [F (1, 25) = 37.4, <italic>p</italic> &lt; .0001], trials [F (5,
125) = 5.19, <italic>p</italic> = .0002] and interaction [F (5, 125) = 1.38,
<italic>p</italic> = .2360] on falling latency. Bonferroni’s post-hoc
test revealed a significant difference in falling latency of AAV-eGFP-Cre mice
(trial 1 AAV-eGFP 61.52 ± 5.466 vs AAV-eGFP-Cre 104.3 ± 6.22:
<italic>p</italic> &lt; .0001; trial 2 AAV-eGFP 49.94 ± 5.615 vs
AAV-eGFP-Cre 84.82 ± 5.487: <italic>p</italic> &lt; .0002; trial 3
AAV-eGFP 67.91 ± 4.34 vs AAV-eGFP-Cre 98.85 ± 4.789:
<italic>p</italic> &lt; .0014; trial 4 AAV-eGFP 64.35 ± 4.988 vs
AAV-eGFP-Cre 94.72 ± 5.995: <italic>p</italic> &lt; .0018; trial 6
AAV-eGFP 72.28 ± 4.11 vs AAV-eGFP-Cre 101.3 ± 9.748:
<italic>p</italic> &lt; .0032). D. In the open field test, no
significant difference was found between AAV-eGFP and AAV-eGFP-Cre injected mice
in total distance traveled (N = 16 for AAV-eGFP and N = 17 AAV-eGFP-Cre;
AAV-eGFP 47.88 ± 4.587 vs AAV-eGFP-Cre 52.78 ± 3.614,
<italic>p</italic> = .4080, unpaired <italic>t</italic>-test). E. Strategy
of deletion of GluD1 from ventral striatum. AAV-eGFP or AAV-eGFP-Cre vectors
were setereotaxically injected into the ventral striatum of
GluD1<sup>flox/flox</sup> mice. F. During the habit acquisition no
significant difference was observed between AAV-eGFP and AAV-eGFP-Cre mice,
(treatment [F (1, 17) = 2.466, <italic>p</italic> = .1347, Two-way repeated
measures ANOVA) (N = 9 for AAV-eGFP and 10 for AAV-eGFP-Cre). F′. No
significant differences were observed in the latency to find the platform,
although a trend for higher latency was observed on day 2 (treatment [F (1, 17)
= 0.9066, <italic>p</italic> = .03544)]). F″-F″’. No
significant differences were observed in total errors (treatment [F (1, 17) =
4.523, <italic>p</italic> = .0484]) or preservative errors (treatment [F (1, 17)
= 4.055, <italic>p</italic> = .0601]) during the reversal learning in
corticolimbic-GluD1 KO. G. In the rotarod test, during test phase no significant
difference in the latency to fall was observed in AAV-eGFP and AAV-eGFP-Cre
injected mice (N = 9 for AAV-eGFP and N = 9 for AAV-eGFP-Cre; Two way repeated
measures ANOVA genotype [F (1, 16) = 0.3285, <italic>p</italic> = .5745], trials
[F (5, 80) = 4.826, <italic>p</italic> = .0007] and interaction [F (5, 80) =
0.3245, <italic>p</italic> = .8968]). H. In the open field test, no significant
difference was found between AAV-eGFP and AAV-eGFP-Cre injected mice in total
distance traveled (N = 9 for AAV-eGFP and <italic>N</italic> = 10 AAV-eGFP-Cre;
AAV-eGFP 54.76 ± 6.085 vs AAV-eGFP-Cre 48.2 ± 4.254,
<italic>p</italic> = .3917, unpaired t-test). All data are presented as mean
± SEM.</p>
</caption>
<graphic xlink:href="nihms-1551653-f0002"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Fig. 3.</label>
<caption>
<p id="P44">GluD1 is preferentially localized in striatal dendrites and co-localized
with vGluT2 puncta. A-B. Light micrographs showing lack of striatal GluD1
immunostaining in GluD1 KO mice, confirming the specificity of the GluD1
antibody used in our study. In A and A’, asterisks indicate areas of
striatum, reminiscent of the striatal patch compartment, with low expression of
GluD1 immunoreactivity. C-E. Examples of GluD1-immunoreactive dendritic shafts
(Den), spines (sp) and glial processes (Gl) in the mouse dorsal striatum.
Unlabeled terminals (u.Te) and spines (u.Sp) are also indicated. Scale bars in
A: 1 mm (valid for B); C: 1 μm (valid for DF). F. Histogram showing the
relative proportion of the different GluD1- positive elements in the mouse
dorsal striatum (<italic>N</italic> = 3 mice; total surface area of tissue
analyzed: 5987.35 μm<sup>2</sup>; total number of labeled elements
sampled: 808). Note the predominance of labeling associated with dendritic
shafts and glial processes compared with spines. G. Confocal images of dorsal
striatum tissue co-labeled with GluD1 and vGluT1 or vGluT2. Arrows indicate
co-localized puncta. Total number of GluD1-labeled punctate structures
co-localized with vGluT1 or vGluT2 puncta per 2000 μm<sup>2</sup>
striatal surface area. A higher percent of GluD1 elements were found in
apposition with vGluT2 than vGluT1 puncta; vGluT1 1.12 ± 1.02 vs. vGluT2
10.31 ± 1.46, <italic>p</italic> = .005, Unpaired t-test (N = 3 animals).
All data are presented as mean ± SEM.</p>
</caption>
<graphic xlink:href="nihms-1551653-f0003"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Fig. 4.</label>
<caption>
<p id="P45">Striatum specific ablation of GluD1 leads to reduced excitatory
neurotransmission in MSNs. A. A significant reduction in the frequency of mEPSC
was observed in St-GluD1 KO (WT: 6.57 ± 0.7 Hz vs. St-GluD1 KO: 2.99
± 0.46 Hz, <italic>p</italic> = .0004, Unpaired <italic>t</italic>-test).
Inter-event interval (IEI) was also significantly reduced (<italic>p</italic> =
.0021, KeS test) (<italic>N</italic> = 11–12 from 3 to 4 animals per
genotype). No change in amplitude was observed (WT: 12.73 ± 0.27 pA vs.
St-GluD1 KO: 12.65 ± 0.55 pA, <italic>p</italic> = .894, Unpaired
<italic>t</italic>-test). B. No significant change in mIPSC frequency or
amplitude was observed (frequency: WT: 1 ± 0.08 Hz vs. St-GluD1 KO: 0.86
± 0.14 Hz, p = .409; amplitude: WT: 11.92 ± 0.69 pA vs. St-GluD1
KO: 12.92 ± 0.8 pA, <italic>p</italic> = .366; Unpaired t-test) (N =
10–12 from 3 to 4 animals per genotype). All data are presented as mean
± SEM. C. Reduced excitability of MSNs in St-GluD1 KO (<italic>N</italic>
= 7–8/genotype from 3 animals; 280 pA: WT 16.86 ± 2.32 Hz vs.
St-GluD1 KO 8 ± 2.6 Hz, <italic>p</italic> = .016; 300 pA: WT 18.29
± 2.27 Hz vs. St-GluD1 KO 9.25 ± 2.58 pA, <italic>p</italic> =
.013; Two-way ANOVA with Bonferroni’s post-hoc test). D. No change in
resting membrane potential (<italic>p</italic> = .9645, unpaired t-test), input
resistance (<italic>p</italic> = .1220, unpaired t-test) or rheobase
(<italic>p</italic> = .4617, unpaired t-test) of MSNs in St-GluD1 KO. All
data are presented as mean ± SEM. E. A significant reduction in the
number of striatal vGluT2, but not vGluT1, puncta was found in St-GluD1 KO
(vGluT1: WT 100 ± 7.703% vs. St-GluD1 KO 112.932 ± 15.469% of WT,
<italic>p</italic> = .5649; vGluT2: WT 100 ± 12.482% vs. St-GluD1 KO
32.482 ± 4.341% of WT, <italic>p</italic> = .0003; unpaired t-test,
<italic>N</italic> = 5 mice/genotype for vGluT1 and 9 mice/genotype for
vGluT2). All data are presented as mean ± SEM.</p>
</caption>
<graphic xlink:href="nihms-1551653-f0004"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Fig. 5.</label>
<caption>
<p id="P46">Specific increase in the AMPA/NMDA ratio at Pf-MSN synapses in St-GluD1
KO. A. Viral vector injections in the Pf (top row) and resulting anterograde
labeling of the thalamic projections in the dorsal striatum (bottom row) in WT
and St-GluD1 KO mice. B. Light-evoked EPSCs (in the presence of picrotoxin
(PCTX)), sensitive to CNQX and AP5, were recorded in striatal MSNs (**
<italic>p</italic> &lt; .01). C. No significant change in paired-pulse
ratio across different inter-stimulus interval was observed between WT and KO
animals [<italic>p</italic> &gt; .876 for all intervals, Two-way ANOVA with
Bonferroni’s post-hoc test (N = 7–10 from 3 to 4 animals per
genotype)]. D. A significant increase in the AMPA/NMDA ratio was observed at
Pf-MSN synapses in St-GluD1 KO [WT 0.35 ± 0.05 vs. St-GluD1 KO 0.98
± 0.24, p = .033; Unpaired t-test (N = 8–10 from 3 to 4 animals
per genotype)]. E. No change in the rectification of AMPA receptor responses in
St-GluD1 KO; <italic>p</italic> &gt; .999 for all voltages; Two-way ANOVA
with Bonferroni’s post-hoc test (<italic>N</italic> = 6 from 3 animals
per genotype). All data are presented as mean ± SEM.</p>
</caption>
<graphic xlink:href="nihms-1551653-f0005"></graphic>
</fig>
<fig id="F6" orientation="portrait" position="float">
<label>Fig. 6.</label>
<caption>
<p id="P47">No change in the function of corticostriatal synapses in St-GluD1 KO. A.
No change was observed in the paired-pulse ratio in St-GluD1 KO;
<italic>p</italic> &gt; .999 for all intervals, Two-way ANOVA with
Bonferroni’s post-hoc test. (N = 10 from 4 mice per genotype). B. No
change in AMPA/NMDA ratio at corticostriatal synapses; WT 2.23 ± 0.19 vs.
St-GluD1 KO 2.33 ± 0.35, <italic>p</italic> = .807, Unpaired t-test (N =
9 from 3 mice per genotype). C. No change in the evoked spike threshold; WT 3.5
± 0.68 mA vs. St-GluD1 KO 3.13 ± 0.39 mA, <italic>p</italic> =
.629, Unpaired t-test (N = 7–8 from 3 mice per genotype). All data are
presented as mean ± SEM.</p>
</caption>
<graphic xlink:href="nihms-1551653-f0006"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>